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We have explored novel synthetic routes for the preparation of 
chondroitin sulfate (CS) oligosaccharides that are based on the use 
of N-tetrachlorophthaloyl (N-TCP) and N-trifluoroacetyl (N-TFA) 
galactosamine building blocks. On the one hand, we have 
performed the total synthesis of two CS disaccharides using N-TCP 
units, demonstrating the compatibility of TCP protection with the 
final deprotection/sulfation steps. However, the 2+2 coupling of N-
TCP containing disaccharides, for the synthesis of CS 
tetrasaccharides, failed. On the contrary, a synthetic route using N- 
TFA galactosamine units efficiently afforded biologically 
relevant CS-like oligosaccharides. The TFA groups could be 
easily removed at the end of the synthesis and microwave 
irradiation greatly facilitated the sulfation reactions. The utility 
of this approach was illustrated with the total synthesis of two 
CS-like tetrasaccharides, with different sulfate distribution. 
Finally, we employed a fluorescence polarization assay to 
estimate the relative ability of the synthesized compounds to 
inhibit the interaction between FGF-2 and heparin. 
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Introduction 
Chondroitin sulfate (CS) is a linear and sulfated polysaccharide 
that belongs to the glycosaminoglycan family.[1] CS is constituted 
by the repetition of disaccharide units of D-glucuronic acid (GlcA)-
β(1→3)-N-acetyl-D-galactosamine (GalNAc)-β(1→4). This 
repeating unit can be sulfated at various positions, giving rise to CS 
polymer chains with different sulfation patterns and a high level of 
structural diversity. In fact, CS chains are classified into different 
types based on the predominant sulfate group distribution, although 
a combination of different patterns is often found in CS samples. 
For instance, CS-A predominantly contains one sulfate at position 
4 of the GalNAc unit, while CS-C has the sulfate group at position 
6 and CS-E owns two sulfates at positions 4 and 6 of the GalNAc 
residue (Figure 1).  
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Figure 1. Some of the typical disaccharide units found in CS.     
CS is involved in important biological processes such as central 
nervous system development[2] and malaria infection.[3] The 
participation of CS in these processes is mediated by certain 
oligosaccharide sequences, with particular sulfate distribution, that 
interact with several protein receptors.[4] For example, CS-E binds 
to several heparin-binding growth factors and chemokines,[5, 6] 
playing important roles in the central nervous system. Recent 
studies indicated that a CS-E tetrasaccharide interacts with midkine, 
a growth factor that participates in the development and repair of 
neural tissues.[7] Interestingly, this interaction requires a specific 
arrangement of sulfate groups since other oligosaccharides, with 
different sulfation motifs, bind significantly weaker (or do not bind 
at all) to midkine. A different class of CS, CS-A, has an important 
role in pregnancy-associated malaria.[8] This subtype of CS binds 
to P. falciparum erythrocyte membrane protein 1 (PfEMP1), a 
critical step for the adhesion of Plasmodium falciparum-infected 
red blood cells to the placenta.        
Due to the heterogeneity of the polymer, structurally defined CS 
oligosaccharides are not easily obtained in sufficient amounts from 
natural sources. Therefore, well-defined synthetic oligosaccharides 
are required for the study of CS-protein interactions at the 
molecular level, the establishment of structure-activity 
relationships and the evaluation of the potential therapeutic 
applications and biological activities of this type of compounds. 
Despite the recent advances in CS oligosaccharides and analogues 
synthesis,[7, 9-19] new approaches to the preparation of these 
molecules are still highly demanded. A careful protecting group 
design is required to obtain the adequate configuration of the 
glycosidic bonds and introduce the sulfate groups at defined 
positions. The choice of the protection for the amino group[20] of 
the GalNAc units is an important point in this design. Most 
reported synthesis of CS oligomers employed N-trichloroacetyl  
galactosamine building blocks.[21] However, the use of this type of 
units presents some limitations. The formation of stable 
trichlorooxazoline side products has been reported in glycosidation 
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reactions of 2-deoxy-2-trichloroacetamido donors.[22-24] 
Additionally, the final transformation of the 2-trichloroacetamido 
to the desired 2-acetamido group can be problematic. The basic 
hydrolysis of multiple trichloroacetamide groups requires very long 
reaction times[22] and the alternative reduction (using 
tributylstannane/AIBN or Zn/acetic acid) affords, in some cases, 
significant amounts of mono- and dichloroacetamide 
intermediates.[25-27] For these reasons, we decided to explore the 
use of new galactosamine monomers that contain a N-
tetrachlorophtaloyl (N-TCP)[28, 29] or a N-trifluroacetyl (N-TFA)[30-
32] protecting group for the synthesis of CS oligosaccharides.             
We envisioned that the TCP group would be a good alternative 
for 2-amino protection because this group avoids the formation of 
stable oxazolines while it strongly favours the formation of the 1,2-
trans glycosidic linkage.[20, 33] Moreover, cleavage of the N-TCP 
moiety does not require the harsh reaction conditions needed for 
the removal of the analogous N-phthaloyl group.[34] On the other 
hand, we envisioned that the TFA group could facilitate the final 
deprotection steps since it can be removed under milder conditions, 
compared to the trichloroacetyl. This group also ensures high β 
selectivities in glycosidation reactions.[35, 36]  Next, we will 
describe the results obtained with both types of building blocks. As 
a first goal, we considered the synthesis of CS tetrasaccharides 
since it has been demonstrated that tetramers are long enough to 
interact with several proteins and exhibit biological activity.[7, 9, 37-
38] 
Results and Discussion 
N-TCP galactosamine building blocks for the synthesis of CS 
oligosaccharides 
We prepared novel GalNAc monomers 1 and 2 (Scheme 1) that can 
be used as glycosyl acceptor and donor, respectively, in coupling 
reactions with glucuronic acid derivatives to afford CS-like 
disaccharides. The 4,6-O-benzylidene acetal will allow the 
selective sulfation of these positions at the end of the synthesis (see 
below). Tetraacetate 3[39] was converted into the 4-methoxyphenyl 
glycoside 4 by treatment with 4-methoxyphenol and BF3·Et2O. De-
O-acetylation of 4 is not trivial due to the base-sensitive nature of 
the N-TCP group and the reported formation of methyl glycoside 
byproducts during the acid-catalyzed hydrolysis of a similar 
glucosamine derivative.[40] Therefore, de-O-acetylation was carried 
out under strictly controlled basic conditions to afford, after 
benzylidenation, compound 1. Donor 2 was prepared from 1 by 
levulination at position 3, followed by oxidative removal of the 4-
methoxyphenyl group with CAN and trichloroacetimidate 
activation.   
 
Scheme 1. Reagents and conditions: a) 4-methoxyphenol, BF3·Et2O, 
CH2Cl2; b) NaOMe, MeOH, 0ºC; c) PhCH(OMe)2, p-TsOH, CH3CN, 50% 
(3 steps, from 3); d) Lev2O, DMAP, CH2Cl2, 92%; e) CAN, 
toluene/CH3CN/H2O, 0ºC, 84%; f) Cl3CCN, DBU, CH2Cl2, 91%. MP = 4-
methoxyphenyl; Lev = levulinoyl; TCA: trichloroacetimidoyl.  
Then, we studied the utility of 1 and 2 in glycosylation reactions 
with glucuronic acid moieties to afford fully protected CS 
disaccharide precursors (Scheme 2). Glucuronic acid 
trichloroacetimidate 8[41, 42]  was coupled with acceptor 1 to give 
disaccharide 9 in good yield. After testing different reaction 
conditions, the best results were obtained with BF3·Et2O as catalyst 
and toluene as solvent. On the other hand, donor 2 was coupled to 
acceptor 10[43] to yield disaccharide 11, with the alternative 
monosaccharide sequence GalNAc-GlcA. In order to introduce an 
amine-terminated linker at the reducing end of the chain, highly 
convenient for further conjugation of the final molecules, 11 was 
transformed into trichloroacetimidate 13. Glycosylation between 
13 and 5-(benzyloxycarbonylamino)-1-pentanol afforded the 
desired disaccharide 14 in good yield.  
With these fully protected disaccharides at hand, we then checked 
the compatibility of the N-TCP group with the 
deprotection/sulfation steps required for the synthesis of final 
deprotected CS oligomers. Thus, starting from 14 we successfully 
prepared disaccharides 15 and 16 that correspond to the sulfation 
patterns of CS-E and CS-C, respectively (Scheme 3). The 
benzylidene acetal of 14 was removed using TFA and the resulting 
diol was extensively sulfated to give 18. Here, the reaction time 
was significantly decreased (40 min) using microwave heating.[44] 
The next step was the basic hydrolysis of the ester groups that 
occurred with concomitant partial hydrolysis of the N-TCP moiety 
to afford 19. The amide bond in 19 was cleaved by treatment with 
ethylenediamine in DMF. This reaction only took 90 min using 
microwave heating.[45, 46] Finally, the amine group of 20 was 
selectively acetylated and the resulting derivative 21 was 
hydrogenated to yield CS-E disaccharide 15 in good yield. For the 
preparation of CS-C dimer 16, diol 17 was heated at 50ºC, under 
microwave irradiation, in the presence of 2 equiv. of SO3·NMe3 
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complex. After stirring for 30 min, the 6-O-sulfated compound 22 
was obtained in high yield. When we carried out the selective 6-
OH sulfation with conventional heating in an oil bath, the reaction 
time was much longer and the yield was lower due to the recovery 
of some unsulfated starting material. Saponification, followed by 
amide bond cleavage, N-acetylation and hydrogenolysis gave final 
disaccharide 16. 
 
Scheme 2. Reagents and conditions: a) BF3·Et2O, toluene, 54% + 27% 
recovered 1; b) TMSOTf, CH2Cl2, 58% + 16% recovered 10; c) CAN, 
CH2Cl2/CH3CN/H2O, 84%; d) Cl3CCN, K2CO3, CH2Cl2, 95%; e) 5-
(benzyloxycarbonylamino)-1-pentanol,  TMSOTf, CH2Cl2, 67%. Z = 
benzyloxycarbonyl.  
 
Scheme 3. Reagents and conditions: a) TFA, CH2Cl2, 0ºC, 99% b) 
SO3·Me3N (10 equiv.), DMF, 100ºC, 40 min, MW, 83%;  c) SO3·Me3N (2 
equiv.), DMF, 50ºC, 30 min, MW, 84%;  d) H2O2, LiOH, THF; NaOH, 
MeOH, 86% for 19, 89% for 23; e) NH2(CH2)2NH2, DMF, 100ºC, 90 min, 
MW; f) Ac2O, Et3N, MeOH, 75% for 21, 88% for 25 (2 steps, from 19 and 
23, respectively); g) H2, Pd(OH)2, H2O/MeOH, quantitative for 15, 
quantitative for 16. 
Next, we attempted the synthesis of longer CS sequences by a 2+2 
coupling of disaccharide units. For this purpose, disaccharide 9 was 
transformed into the corresponding glycosyl acceptor (by 
delevulination) and donor (by cleavage of the anomeric 4-
methoxyphenyl group and trichloroacetimidate formation). 
Unfortunately, the 2+2 glycosylation failed and the desired (GlcA-
GalNAc)2 tetrasaccharide could not be isolated. Alternatively, we 
tried the preparation of a (GalNAc-GlcA)2 tetrasaccharide from 
compound 11. Similarly, 11 was converted into the corresponding 
acceptor and donor disaccharides, but the 2+2 condensation of 
these units failed again. In all these glycosylation trials, most 
starting glycosyl acceptor was recovered from the reaction mixture.          
Synthesis of CS oligomers using N-TFA-protected 
galactosamine units    
For the synthesis of biologically relevant CS tetrasaccharides, we 
turned our attention to N-TFA-protected GalNAc units. We have 
previously reported the preparation and use of this type of building 
blocks for the synthesis of a hybrid chondroitin/dermatan sulfate 
oligosaccharide,[43] owning both GlcA and L-iduronic acid (IdoA). 
Monosaccharide 26, containing a 4,6-O-di-tert-butylsilylene group, 
acted as an excellent glycosyl acceptor in coupling reaction with 
poorly reactive GlcA trichloroacetimidate 27 to generate key 
intermediate 28 (Scheme 4).[43]  
 
Scheme 4. Synthesis of key disaccharide 28 using N-TFA unit 26. 
Here, we expand the utility of this N-TFA monomer to the 
preparation of a CS tetrasaccharide sequence, containing 
exclusively GlcA (Scheme 5). For this purpose, we planned a 2+2 
condensation of appropriate disaccharide derivatives. First, 28 was 
transformed into a suitable donor containing acyl groups at 
positions 4 and 6 of the GalNAc moiety in order to obtain 
selectively the β (1→4) glycosidic bond. Thus, compound 28 was 
treated with (HF)n·Py and then with levulinic anhydride and 
DMAP to yield disaccharide 29. Trichloroacetimidate 31 was 
obtained by cleavage of the anomeric 4-methoxyphenyl group 
followed by treatment with trichloroacetonitrile and DBU. 
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Coupling between 31 and 32[43] gave tetrasaccharide 33 in good 
yield. Importantly, 31 was prepared immediately before its use in 
the glycosidation reaction since we observed partial decomposition 
of this trichloroacetimidate after extended storage, even at low 
temperature (-28ºC/4ºC range).  Tetrasaccharide 33 has a versatile 
protecting group distribution that paves the way to the preparation 
of CS sequences with different sulfation motifs. We decided to 
prepare, for the first time, non-natural oversulfated compound 38 
since we have found that analogous IdoA-containing 
tetrasaccharides (Figure 3, see below) are able to interact with 
FGF-2 (basic fibroblast growth factor), a heparin-binding protein 
involved in angiogenesis. Thus, removal of the silylene group was 
followed by basic hydrolysis and selective N-acetylation to afford 
36. Treatment with SO3·NMe3 complex at 100ºC using microwave 
irradiation[47] gave hepta-O-sulfated tetrasaccharide 37. The 
introduction of the sulfate groups at the desired positions was 
confirmed by the 1H and 13C NMR data that showed the typical 
downfield shifts for the sulfated positions (Tables 1 and 2). Finally, 
hydrogenolysis of 37 yielded the fully deprotected CS tetramer 38. 
NMR analysis confirmed the structure of 38. 1H and 13C NMR data 
are in full agreement with those reported for similar CS derivatives.  
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Scheme 5. Reagents and conditions: a) (HF)n·Py, THF, 0ºC; Lev2O, Py, 
DMAP, 83%; b) CAN, CH2Cl2/CH3CN/H2O, 81%; c) Cl3CCN, DBU, 
CH2Cl2, 70%; d) TMSOTf, CH2Cl2, 0ºC, 71%; e) (HF)n·Py, THF, 0ºC, 
75%; f) LiOH, H2O2, THF; NaOH, MeOH; g) Ac2O, MeOH, Et3N, 90% (2 
steps, from 34); h) SO3·Me3N, DMF, 100ºC, MW, 2 h, 56%; i) H2, Pd(OH)2, 
H2O/MeOH, 97%. 
Table 1. 1H-NMR chemical shifts for sulfated positions of compounds 37 and 38 and the corresponding non-sulfated positions of 36. 
Compound H-4A H-6A H-2B H-4C H-6C H-2D H-4D 
36[a] 4.19-4.12 3.86-3.56 3.46 4.19-4.12 3.86-3.56 3.41 3.72-3.56 
37[b] 4.96 4.36-4.10 4.41 4.96 4.36-4.10 4.41 4.93-4.85 
38[b] 4.95 4.36-4.21 4.28-4.21 4.93 4.36-4.21 4.28-4.21 4.51 
[a] sodium salt, in MeOD; [b]sodium salt, in D2O 
Table 2. 13C-NMR chemical shifts for sulfated positions of compounds 37 and 38 and the corresponding non-sulfated positions of 36. 
Compound C-4A C-6A C-2B C-4C C-6C C-2D C-4D 
36[a] 67.6 61.1 72.7 67.6 61.1 73.0 -[c] 
37[b] 76.9 69.3-68.6 80.0 76.9 69.3-68.6 80.0 77.2 
38[b] 77.0 69.0-68.7 80.7 77.0 69.0-68.7 80.7 79.0 
[a] sodium salt, in MeOD; [b] sodium salt, in D2O; [c] not determined
 As mentioned before, 38 is an oversulfated CS sequence 
containing a sulfation pattern not found in nature. In order to 
demonstrate that N-TFA building blocks can be also employed for 
the preparation of oligosaccharides with naturally occurring sulfate 
distributions, we synthesized, for the first time, tetrasaccharide 50 
(Scheme 6). This compound contains sulfate groups at positions 4 
and 6 of the GalNAc units, the sulfation pattern of biologically 
relevant CS-E. Moreover, 50 has a IdoA unit at the non-reducing 
end. It has been reported that the presence of IdoA (instead of 
GlcA) in CS chains, giving rise to hybrid chondroitin/dermatan 
sulfate copolymers, has critical roles in the central nervous system 
development.[2, 48] Oligosaccharide sequences containing 
GlcA/IdoA-GalNAc (4,6-OSO3-) interact with L- and P-selectin 
and several chemokines and heparin-binding growth factors.[6, 49] 
The chemical synthesis of these structures, containing both GlcA 
and IdoA, will contribute to determine the role of hybrid sequences 
in biological processes including stem cell proliferation, 
neurogenesis and neural network formation.  
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Scheme 6. Building blocks required for the synthesis of tetrasaccharide 50. 
Tetrasaccharide 50 was obtained from disaccharides 39[43] and 32 
(Scheme 6). The protecting groups of 39 were rearranged to 
produce the E sulfation pattern at the end of the synthesis. 
Delevulination followed by pivaloylation afforded compound 40 
(Scheme 7). The silylene group was then changed by two 
levulinoyl groups (→41) that allow the selective deprotection and 
subsequent sulfation at positions 4 and 6 of the GalNAc moiety and, 
at the same time, favour the adequate stereochemistry of the 
glycosidic bond in the 2+2 condensation. Formation of the 
trichloroacetimidate 43 was then achieved by oxidative removal of 
the anomeric 4-methoxyphenyl group with CAN followed by 
treatment with trichloroacetonitrile and DBU. Fully protected 
tetramer 44 was prepared by glycosylation of 43 and 32. The 
protecting group distribution of 44 can lead, among others, to a CS-
E sulfation motif. Treatment with hydrazine monohydrate and then 
with (HF)n·Py complex gave tetraol 46. The released hydroxyl 
groups were sulfated in 30 min, using microwave heating, to yield 
47. 1H NMR spectrum of 47 showed the expected downfield shifts 
for H-4 GalNAc (4.14-3.93 ppm in 46; 4.85-4.80 ppm in 47) and 
H-6a,b GalNAc (3.83-3.48 ppm in 46; 4.52-4.25 in 47). 13C NMR 
spectrum of 47 also showed the expected downfield shifts of the 
signals for C-4 GalNAc (68.6 ppm in 46; 75.4-75.1 ppm in 47) and 
C-6 GalNAc (62.7-62.5 ppm in 46; 68.0-67.5 ppm in 47). 
Hydrolysis of ester and amide functions followed by N-acetylation 
and hydrogenolysis afforded tetrasaccharide 50 in high yield. The 
structure of this compound was confirmed by NMR (COSY, 
TOCSY and HSQC experiments) and mass spectroscopy. 1H and 
13C NMR chemical shifts are in good agreement with those 
published for similar oligosaccharides.   
 
Scheme 7. Reagents and conditions: a) NH2NH2·H2O, Py/AcOH, CH2Cl2; 
PivCl, DMAP, Py, 87%; b) (HF)n·Py, THF, 0ºC; Lev2O, Py, DMAP, 81%; 
c) CAN, CH2Cl2/CH3CN/H2O, 70%; d) Cl3CCN, DBU, CH2Cl2, 78%; e) 32, 
TMSOTf, CH2Cl2, 0ºC, 53%; f) NH2NH2·H2O, Py/AcOH, CH2Cl2, 87%; g) 
(HF)n·Py, THF, 0ºC, 97%; h) SO3·Me3N, DMF, 100ºC, MW, 30 min, 
quantitative; i) LiOH, H2O2, THF; NaOH, MeOH; j) Ac2O, MeOH, Et3N, 
86% (2 steps, from 47); k) H2, Pd(OH)2, H2O/MeOH, quantitative. 
Fluorescence polarization competition assay 
FGF-2 is a heparin-binding protein[50, 51] that also recognizes CS 
sequences.[5] We finally screened the interactions between FGF-2 
and the synthesized water-soluble CS oligosaccharides (15, 16, 38, 
50 and the dibenzylated tetrasaccharide precursors 37 and 49). For 
this purpose, we employed a fluorescence polarization competition 
assay, previously developed in our group,[43] in which we measured 
the relative ability of the synthetic CS oligomers to inhibit the 
interaction between FGF-2 and a fluorescent labelled heparin probe. 
Briefly, the fluorescence polarization of samples containing fixed 
concentrations of protein and fluorescent probe were measured in 
the presence of the different CS oligosaccharides (Figure 2). The 
binding of a CS oligomer to FGF-2 would displace the fluorescent 
probe from its complex with the protein, resulting in a decrease of 
the polarization value. In this experiment we included two control 
samples (in white, Figure 2). The first one (in the left) only 
contained fluorescent probe and indicated the expected value for 
100 % inhibition. The second one (in the right) contained FGF-2 
and fluorescent probe, without inhibitor, and indicated the expected 
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value for 0% inhibition. As shown in Figure 2, at 25 µM inhibitor 
concentration, disaccharides 15 and 16 and tetrasaccharides 49 and 
50 only showed low inhibitory activity, while compounds 37 and 
38 were able to inhibit 47 and 63%, respectively, of the interaction. 
However, the inhibitory activities of oversulfated 37 and 38 were 
lower than those obtained with previously synthesized IdoA-
containing tetrasaccharides 51 and 52 (Figure 3).[43] In summary, 
these data indicate that oversulfated, non-natural tetrasaccharides 
(37-38, 51-52) display stronger inhibitory abilities that those 
containing natural sulfation patterns (49, 50). These results also 
suggest that the presence of an IdoA unit, instead of a GlcA, at the 
nonreducing end of oversulfated structures, as in compounds 51 
and 52, can increase the relative binding affinities of the synthetic 
non-natural CS oligosaccharides to FGF-2. The interaction 
between FGF-2 and heparin is crucial for tumor growth and 
angiogenesis. Therefore, the discovery of compounds that inhibit 
the FGF-2/heparin interaction is an area of great interest.[52, 53] 
Although the tested compounds displayed modest activities, this 
experiment gives some interesting data on the structural features 
for inhibition of heparin binding to FGF-2. Moreover, this assay 
illustrates the potential of our fluorescence polarization method for 
the fast comparison of relative inhibitory activities. 
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Figure 2. Competition assay to compare the relative inhibitory potencies of 
the synthetic CS-like oligosaccharides. The graphic presents (in grey) the 
polarization values obtained from wells containing 25 µM inhibitor, 73 nM 
FGF-2, and 10 nM fluorescent heparin-like probe. The composition of 
control wells (in white) is described in the main text. All the measurements 
are the average of three replicate wells and the error bars show the standard 
deviations for these measurements. 
 
Figure 3. Structure of IdoA containing tetrasaccharides 51 and 52. 
 
 
Conclusions 
We have explored and compared the utility of two differently 
protected galactosamine units for the preparation of CS 
oligosaccharides. Although N-TCP protection was useful at the 
disaccharide level, we were not able to synthesize longer sequences 
with this type of units. On the contrary, we have showed that a 
strategy based on N-TFA building blocks can afford biologically 
relevant CS oligosaccharides in good yield.  The efficiency of this 
approach was exemplified by the synthesis of two novel CS-like 
tetrasaccharides, with different sulfation pattern and uronic acid 
distribution. TFA groups led to the stereoselective formation of 
1,2-trans glycosidic bonds and could be easily removed at the end 
of the synthesis. Microwave irradiation facilitated sulfation 
reactions. Finally, we compared the abilities of the synthetic CS 
oligosaccharides to inhibit heparin binding to FGF-2, obtaining 
some interesting information on the structural features for 
inhibitory activity. 
Experimental Section 
General procedures: Thin layer chromatography (TLC) analyses were 
performed on silica gel 60 F254 precoated on aluminium plates (Merck) and 
the compounds were detected by staining with sulfuric acid/ethanol (1:9), 
with cerium (IV) sulfate (10 g)/phosphomolybdic acid (13 g)/sulfuric acid 
(60 mL) solution in water (1 L), or with anisaldehyde solution 
[anisaldehyde (25 mL) with sulfuric acid (25 mL), ethanol (450 mL) and 
acetic acid (1 mL)], followed by heating at over 200ºC. Column 
chromatography was carried out on silica gel 60 (0.2-0.5 mm, 0.2-0.063 
mm or 0.040-0.015 mm; Merck). Optical rotations were determined with a 
Perkin-Elmer 341 polarimeter. 1H- and 13C-NMR spectra were acquired on 
Bruker DPX-300, Avance III-400 and DRX-500 spectrometers. Unit A 
refers to the reducing end monosaccharide in the NMR data. Electrospray 
mass spectra (ESI MS) were carried out with an Esquire 6000 ESI-Ion Trap 
from Bruker Daltonics. High resolution mass spectra (HR MS) were carried 
out by CITIUS (Universidad de Sevilla), CCiT (Universitat de Barcelona) 
and SIdI (Universidad Autónoma de Madrid). Microwave-based sulfation 
reactions were performed using a Biotage Initiator Eight synthesizer in 
sealed reaction vessels. 
4-Methoxyphenyl 4,6-O-benzylidene-2-deoxy-2-
tetrachlorophthalimido-β-D-galactopyranoside (1): BF3·Et2O (731 µL, 
5.82 mmol) was added under an argon atmosphere at 0ºC to a mixture of 3 
(1.79 g, 2.91 mmol) and 4-methoxyphenol (723 mg, 5.82 mmol) in dry 
CH2Cl2 (8.0 mL). The temperature was gradually raised to room 
temperature during 2 h, and the mixture was stirred for 24 h, diluted with 
CH2Cl2 (40 mL), and washed with H2O, saturated aqueous NaHCO3, and 
H2O. The organic phase was dried (MgSO4) and concentrated to dryness. 
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The residue was purified by column chromatography (hexane-EtOAc 3:1) 
to afford 4 (1.63 g). TLC (toluene-acetone 3:2) Rf 0.44; 1H-NMR (300 
MHz, CDCl3): δ 6.86 (m, 2H, Ar), 6.75 (m, 2H, Ar), 5.79 (d, 1H, J1,2=8.5 
Hz, H-1), 5.78 (dd, 1H, J2,3=11.3 Hz, J3,4=3.1 Hz, H-3), 5.53 (d, 1H, H-4), 
4.79 (dd, 1H, H-2), 4.28-4.10 (m, 3H, H-5, H-6a, H-6b), 3.74 (s, 3H, 
Me(OMP)), 2.23, 2.06, 1.91 (3s, 9H, OAc); ESI MS: m/z: calcd for 
C27H23Cl4NO11Na: 700.0; found: 700.1 [M+Na]+. 
Compound 4 (1.63 g, 2.4 mmol) was dissolved in MeOH (186 mL), and 
MeONa/MeOH (1M, 3.2 mL) was added. The mixture was stirred at 0ºC 
for 10 min, and AcOH (15.5 mL) was added. The mixture was stirred at 
room temperature for 10 min and co-concentrated twice with toluene. The 
residue was filtered through a silica column (toluene-acetone 2:1) to give 5 
(855 mg) and a mixture of partially deacetylated compounds (348 mg). The 
partially deprotected products were dissolved in MeOH (40 mL) and treated 
with additional MeONa (0.68 mL of a 1M solution in MeOH) at 0ºC. After 
stirring for 7 min at 0ºC, AcOH (3.3 mL) was added and the mixture was 
concentrated. The residue was purified by column chromatography to give 
additional 5 (197 mg). TLC (toluene-acetone 2:1) Rf 0.29; 1H-NMR (300 
MHz, CDCl3): δ 6.87 (m, 2H, Ar), 6.74 (m, 2H, Ar), 5.62 (d, 1H, J1,2=8.4 
Hz, H-1), 4.61 (bt, 1H, H-2), 4.46 (dd, 1H, J2,3=11.0 Hz, J3,4=3.0 Hz, H-3), 
4.03 (d, 1H, H-4), 3.84-3.75 (m, 3H, H-5, H-6a, H-6b), 3.69 (s, 3H, 
Me(OMP)); ESI MS: m/z: calcd for C21H17Cl4NO8Na: 574.0; found: 574.1 
[M+Na]+. 
Compound 5 (1.052 g, 1.90 mmol) was dissolved in dry MeCN (19 mL). 
Benzaldehyde dimethyl acetal (0.43 mL, 2.85 mmol) and p-TsOH (188 µL 
of a 0.5 M solution in dry MeCN) were added, and the mixture was stirred 
for 45 min, diluted with EtOAc (200 mL), and washed with saturated 
aqueous NaHCO3, and H2O. The organic phase was dried (MgSO4) and 
concentrated to dryness. The residue was purified by column 
chromatography (toluene-EtOAc 8:1) to afford 1 (930 mg, 50% from 3, 3 
steps). TLC (toluene-EtOAc 8:1) Rf 0.27; [α]20D +11º (c 1.0, CHCl3); 
1H-NMR (300 MHz, CDCl3): δ 7.55 (m, 2H, Ar), 7.40 (m, 3H, Ar), 6.91 (m, 
2H, Ar), 6.75 (m, 2H, Ar), 5.75 (d, 1H, J1,2=8.3 Hz, H-1), 5.61 (s, 1H, Ph-
CH), 4.69 (bt, 1H, H-2), 4.51 (dd, 1H, J2,3=10.9 Hz, J3,4=3.1 Hz, H-3), 4.38 
(d, 1H, J6a,6b=12.4 Hz, H-6a), 4.33 (bd, 1H, H-4), 4.13 (d, 1H, H-6b), 3.73 
(s, 3H, Me(OMP)), 3.70 (s, 1H, H-5); 13C-NMR (75 MHz, CDCl3): δ 164.2, 
163.6 (2CO), 155.8, 150.6, 140.5, 140.4, 137.3, 130.1, 129.8 (Ar-C), 129.6, 
128.5 (Ar-CH), 127.6, 127.3 (Ar-C), 126.6, 119.3, 114.5 (Ar-CH), 101.7 
(Ph-CH), 97.6 (C-1), 74.9 (C-4), 69.2 (C-6), 67.8 (C-3), 67.0 (C-5), 55.7 
(Me(OMP)), 55.4 (C-2); HR MS: m/z: calcd for C28H21Cl4NO8Na: 
661.9919; found: 661.9899 [M+Na]+. 
4-Methoxyphenyl 4,6-O-benzylidene-2-deoxy-3-O-levulinoyl-2-
tetrachlorophthalimido-β-D-galactopyranoside (6): Lev2O preparation: 
LevOH (2.0 mL, 19.1 mmol) was added at 0ºC to a solution of 1,3-
dicyclohexylcarbodiimide (1.97 g, 9.54 mmol) in CH2Cl2 (16 mL). After 
stirring 5 min at room temperature, the mixture was cooled and filtered, and 
the urea precipitate was washed with additional CH2Cl2 (2.7 mL), to give 
18.7 mL of a 0.51 M Lev2O solution. 
Lev2O (16.4 mL of a 0.51 M solution in CH2Cl2) was added at room 
temperature to a mixture of 1 (2.16 g, 3.37 mmol) and DMAP (61.1 mg, 
0.51 mmol). The mixture was stirred for 1 h 30 min, diluted with CH2Cl2, 
and washed with saturated aqueous NaHCO3, and H2O. The organic phase 
was dried (MgSO4), filtered and concentrated to dryness. The residue was 
purified by column chromatography (toluene-EtOAc 9:1) to afford 6 (2.29 
g, 92%). TLC (toluene-EtOAc 6:1) Rf 0.31; [α]20D +14º (c 1.0, CHCl3); 
1H-NMR (300 MHz, CDCl3): δ 7.60-7.55 (m, 2H, Ar), 7.42-7.38 (m, 3H, 
Ar), 6.90 (m, 2H, Ar), 6.74 (m, 2H, Ar), 5.82 (d, 1H, J1,2 = 8.5 Hz, H-1), 
5.80 (dd, 1H,  J2,3 = 11.4 Hz, J3,4 = 3.6 Hz, H-3), 5.58 (s, 1H, Ph-CH), 5.00 
(dd, 1H, H-2), 4.45 (bd, 1H, H-4), 4.37 (dd, 1H, J5,6a = 1.4 Hz, J6a,6b = 12.5 
Hz, H-6a), 4.12 (dd, 1H, J5,6b = 1.4 Hz, H-6b), 3.73 (s, 3H, Me(OMP)), 3.72 
(m, 1H, H-5), 2.76-2.39 (m, 4H, CH2(Lev)), 1.93 (s, 3H, CH3(Lev)); 
13C-NMR (75 MHz, CDCl3): δ 206.4 (CO(Lev)), 172.0 (CO(Lev)), 164.0, 
163.0 (2CO), 155.8, 150.5, 140.3, 140.2, 137.6, 130.1, 129.9 (Ar-C), 129.3, 
128.4 (Ar-CH), 127.7, 127.4 (Ar-C), 126.5, 119.3, 114.5 (Ar-CH), 101.1 
(Ph-CH), 97.6 (C-1), 73.0 (C-4), 69.1 (C-6), 68.7 (C-3), 66.9 (C-5), 55.7 
(Me(OMP)), 51.7 (C-2), 37.9 (CH2(Lev)), 29.6 (CH3(Lev)), 28.2 
(CH2(Lev)); HR MS: m/z: calcd for C33H27Cl4NO10Na: 760.0287; found: 
760.0278 [M+Na]+. 
4,6-O-Benzylidene-2-deoxy-3-O-levulinoyl-2-tetrachlorophthalimido-
α,β-D-galactopyranose (7): CAN (6.65 g, 11.9 mmol) was added at 0ºC to 
a solution of 6 (2.2 g, 3.0 mmol) in toluene/MeCN/H2O (1:6:1; 104 mL). 
After stirring for 1 h at 0ºC, the mixture was diluted with EtOAc, washed 
with H2O, saturated aqueous NaHCO3, and H2O. The organic phase was 
dried (MgSO4), filtered and concentrated to dryness. The residue was 
purified by column chromatography (toluene-EtOAc 4:1) to afford 7 (1.60 
g, 84%) as a mixture of α/β anomers (2:10).  TLC (toluene-EtOAc 4:1) Rf 
0.23 (for a mixture of α/β anomers); 1H-NMR (300 MHz, CDCl3) (data for 
β anomer): δ 7.55-7.48 (m, 2H, Ar), 7.39-7.33 (m, 3H, Ar), 5.77 (dd, 1H,  
J2,3 = 11.3 Hz, J3,4 = 3.5 Hz, H-3), 5.54 (s, 1H, Ph-CH), 5.47 (d, 1H, J1,2 = 
8.3 Hz, H-1), 4.67 (dd, 1H, H-2), 4.40 (bd, 1H, H-4), 4.34 (dd, 1H, J5,6a = 
1.4 Hz, J6a,6b = 12.6 Hz, H-6a), 4.08 (dd, 1H, J5,6b = 1.4 Hz, H-6b), 3.84 (bs, 
1H, OH), 3.67 (m, 1H, H-5), 2.69-2.35 (m, 4H, CH2(Lev)), 1.91 (s, 3H, 
CH3(Lev)); 13C-NMR (75 MHz, CDCl3) (data for β anomer): δ 206.5 
(CO(Lev)), 171.9 (CO(Lev)), 163.8, 163.5 (2CO), 140.1, 137.5, 129.9, 
129.8 (Ar-C), 129.3, 128.3 (Ar-CH), 127.6, 127.5 (Ar-C), 126.3 (Ar-CH), 
100.9 (Ph-CH), 92.8 (C-1), 72.9 (C-4), 69.2 (C-6), 68.5 (C-3), 66.9 (C-5), 
53.5 (C-2), 37.9 (CH2(Lev)), 29.6 (CH3(Lev)), 28.2 (CH2(Lev)); 1H-NMR 
(300 MHz, CDCl3) (data for α anomer): δ 7.55-7.48 (m, 2H, Ar), 7.39-7.33 
(m, 3H, Ar), 6.33 (dd, 1H,  J2,3 = 12.1 Hz, J3,4 = 3.4 Hz, H-3), 5.57 (s, 1H, 
Ph-CH), 5.50 (m, 1H, H-1), 5.04 (dd, 1H, J1,2 = 3.1 Hz, H-2), 4.57 (bd, 1H, 
H-4), 4.26 (bd, 1H, J6a,6b = 12.2 Hz, H-6a), 4.14-4.07 (m, 2H, H-5, H-6b), 
4.00 (bs, 1H, OH), 2.69-2.35 (m, 4H, CH2(Lev)), 1.97 (s, 3H, CH3(Lev)); 
13C-NMR (75 MHz, CDCl3) (significant data for α anomer): δ 93.0 (C-1), 
73.3 (C-4), 69.5 (C-6), 65.5 (C-3), 62.6 (C-5), 51.3 (C-2); HR MS: m/z: 
calcd for C26H21Cl4NO9Na: 653.9868; found: 653.9876 [M+Na]+. 
O-(4,6-O-Benzylidene-2-deoxy-3-O-levulinoyl-2-
tetrachlorophthalimido-β-D-galactopyranosyl) trichloroacetimidate (2): 
Trichloroacetonitrile (5.3 mL, 54 mmol) and catalytic DBU (96 µL of a 
0.11 M solution in dry CH2Cl2) were added to a solution of 7 (680 mg, 1.07 
mmol) in dry CH2Cl2 (15 mL). After stirring for 7 h at room temperature, 
the reaction mixture was concentrated to dryness. The residue was purified 
by flash chromatography (toluene-EtOAc 5:1 + 1% Et3N) to afford 2 (763 
mg, 91%). TLC (toluene-EtOAc 3:1) Rf 0.40; 1H-NMR (300 MHz, CDCl3): 
δ 8.64 (s, 1H, NH), 7.57 (m, 2H, Ar), 7.41 (m, 3H, Ar), 6.54 (d, 1H, J1,2 = 
8.9 Hz, H-1), 5.90 (dd, 1H,  J2,3 = 11.4 Hz, J3,4 = 3.6 Hz, H-3), 5.59 (s, 1H, 
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Ph-CH), 5.05 (dd, 1H, H-2), 4.49 (d, 1H, H-4), 4.43 (d, 1H, J6a,6b = 12.4 Hz, 
H-6a), 4.14 (d, 1H, H-6b), 3.87 (bs, 1H, H-5), 2.71-2.41 (m, 4H, CH2(Lev)), 
1.93 (s, 3H, CH3(Lev)); ESI MS: m/z: calcd for C28H21Cl7N2O9Na: 796.9; 
found: 797.0 [M+Na]+.  
4-Methoxyphenyl 3-O-(methyl 2,3-di-O-benzoyl-4-O-levulinoyl-β-D-
glucopyranosyluronate)-4,6-O-benzylidene-2-deoxy-2-
tetrachlorophthalimido-β-D-galactopyranoside (9): BF3·Et2O (326 µL of 
a 0.26 M solution in dry toluene) was added under an argon atmosphere at 
room temperature to a mixture of 1 (154 mg, 0.24 mmol) and 8 (475 mg, 
0.72 mmol) containing freshly activated 4Å molecular sieves in dry toluene 
(2.5 mL). After stirring for 45 min at room temperature, the reaction 
mixture was neutralized with Et3N and concentrated to dryness. The residue 
was purified by column chromatography (toluene-acetone 8:1) to afford 9 
(148 mg, 54%) and unreacted acceptor (41 mg, 27%). TLC (toluene-
acetone 3:1) Rf 0.48; [α]20D +18º (c 1.0, CHCl3); 1H-NMR (300 MHz, 
CDCl3): δ 7.76-7.09 (m, 15H, Ar), 6.79 (m, 2H, Ar), 6.68 (m, 2H, Ar), 5.64 
(t, 1H, J2,3 = J3,4 = 9.5 Hz, H-3B), 5.59 (s, 1H, PhCH), 5.49 (d, 1H, J1,2 = 8.3 
Hz, H-1A), 5.41 (t, 1H, J4,5 = 9.6 Hz, H-4B), 5.34 (dd, 1H, J1,2 = 7.6 Hz, H-
2B), 5.07 (d, 1H, H-1B), 4.99 (dd, 1H, J2,3 = 11.3 Hz, H-2A), 4.82 (dd, 1H, 
J3,4 = 3.2 Hz, H-3A), 4.63 (bd, 1H, H-4A), 4.36 (bd, 1H, J6a,6b = 12.2 Hz, H-
6aA), 4.24 (d, 1H, H-5B), 4.13 (bd, 1H, H-6bA), 3.72, 3.69 (2s, 6H, 
COOMe, Me(OMP)), 2.66-2.30 (m, 4H, CH2(Lev)), 2.03 (m, 3H, 
CH3(Lev)); 13C-NMR (75 MHz, CDCl3): δ 171.3, 167.0, 165.6, 164.4, 
164.1, 162.0 (CO(Lev, NTCP, COOMe, Bz), 155.6, 150.5, 140.3, 140.0, 
137.7 (Ar-C), 133.5, 133.1, 129.9-125.4, 119.0, 114.4 (Ar-CH, Ar-C), 
101.7 (C-1B), 100.9 (PhCH), 97.7 (C-1A), 76.2 (C-3A), 75.1 (C-4A), 72.3 
(C-5B), 72.2 (C-3B), 71.9 (C-2B), 69.4 (C-4B), 69.0 (C-6A), 66.9 (C-5A), 
55.5, 52.9 (COOMe, Me(OMP)), 52.0 (C-2A), 37.4 (CH2(Lev)), 29.5 
(CH3(Lev)), 27.6 (CH2(Lev)); HR MS: m/z: calcd for C54H45Cl4NO18Na: 
1158.1288; found: 1158.1327 [M+Na]+. 
Benzyl [4-Methoxyphenyl 2-O-benzoyl-3-O-benzyl-4-O-(4,6-O-
benzylidene-2-deoxy-3-O-levulinoyl-2-tetrachlorophthalimido-β-D-
galactopyranosyl)-β-D-glucopyranoside]uronate (11): Donor 2 (655 mg, 
0.842 mmol) and acceptor 10 (274 mg, 0.468 mmol) were dissolved in dry 
CH2Cl2 (5 mL) in the presence of freshly activated 4Å molecular sieves. 
After stirring for 10 min at room temperature, TMSOTf (229 µL of a 0.18 
M solution in dry CH2Cl2) was added under an argon atmosphere. After 
stirring for 9 min, the reaction mixture was neutralized with Et3N and 
concentrated to dryness. The residue was purified by column 
chromatography (toluene-EtOAc 9:1) to afford 11 (325 mg, 58%) and 
unreacted 10 (45 mg, 16%). TLC (toluene-EtOAc 4:1) Rf 0.43; [α]20D –9º (c 
1.0, CH2Cl2); 1H-NMR (300 MHz, CDCl3): δ 7.94 (m, 2H, Ar), 7.56 (m, 1H, 
Ar), 7.48-7.15 (m, 17H, Ar), 6.77 (m, 2H, Ar), 6.64 (m, 2H, Ar), 5.75 (dd, 
1H, J2,3 = 11.4 Hz, J3,4 = 3.6 Hz, H-3B), 5.48 (s, 1H, PhCH), 5.46 (dd, 1H, 
J1,2 = 7.4 Hz, J2,3 = 8.6 Hz, H-2A), 5.38 (d, 1H, J1,2 = 8.4 Hz, H-1B), 5.20 (d, 
1H, CH2(Bn)), 5.04 (d, 1H, CH2(Bn)), 4.99 (d, 1H, CH2(Bn)), 4.91 (d, 1H, 
H-1A), 4.81 (d, 1H, CH2(Bn)), 4.70 (dd, 1H, H-2B), 4.36 (t, 1H, J3,4 = J4,5 = 
9.0 Hz, H-4A), 4.31 (d, 1H, H-4B), 4.17 (d, 1H, J6a,6b = 12.4 Hz, H-6aB), 
3.95-3.89 (m, 2H, H-3A, H-5A), 3.86 (d, 1H, H-6bB), 3.69 (s, 3H, 
Me(OMP)), 3.19 (bs, 1H, H-5B), 2.69-2.32 (m, 4H, CH2(Lev)), 1.92 (s, 3H, 
CH3(Lev)); 13C-NMR (75 MHz, CDCl3): δ 206.3 (CO(Lev)), 171.9, 167.3, 
165.1, 164.2, 163.4 (CO(Lev, NTCP, COOBn, Bz), 155.8, 151.0, 140.0, 
139.8, 138.3, 137.7, 135.1 (Ar-C), 133.3 (Ar-CH), 130.0, 129.8, 129.7, 
129.5, 129.1, 128.7, 128.5, 128.2, 128.1, 127.9, 127.6, 127.3, 126.4 (Ar-C, 
Ar-CH), 119.1, 114.5 (Ar-CH), 101.1, 101.0 (PhCH, C-1A), 97.9 (C-1B), 
80.2 (C-3A or C-5A), 77.8 (C-4A), 74.7 (C-3A or C-5A), 74.5 (CH2(Bn)), 
73.0 (C-2A), 72.7 (C-4B), 68.9 (C-6B), 68.3 (C-3B), 67.5 (CH2(Bn)), 66.4 
(C-5B), 55.7 (Me(OMP)), 52.0 (C-2B), 37.9 (CH2(Lev)), 29.6 (CH3(Lev)), 
28.2 (CH2(Lev)); HR MS: m/z: calcd for C60H51Cl4NO17Na: 1220.1809; 
found: 1220.1812 [M+Na]+.  
Benzyl [2-O-benzoyl-3-O-benzyl-4-O-(4,6-O-benzylidene-2-deoxy-3-O-
levulinoyl-2-tetrachlorophthalimido-β-D-galactopyranosyl)-α,β-D-
glucopyranose]uronate (12): A solution of CAN (79 mg, 0.14 mmol) in 
H2O (0.3 mL) was added to a solution of 11 (42 mg, 0.035mmol) in 
CH2Cl2/MeCN (1:2; 2.7 mL). The mixture was vigorously stirred for 1 h at 
room temperature, then diluted with EtOAc, washed with H2O, saturated 
aqueous NaHCO3, and H2O. The organic phase was dried (MgSO4), filtered 
and concentrated to dryness. The residue was purified by column 
chromatography (CH2Cl2-MeOH 80:1) to afford 12 (40 mg, 84%) as a 
mixture of α/β anomers (2:1). TLC (CH2Cl2-MeOH 80:1) Rf 0.23, 0.27; 
1H-NMR (300 MHz, CDCl3) (for major anomer (α)): δ 7.94 (m, 2H, Ar), 
7.58-7.07 (m, 18H, Ar), 5.69 (dd, 1H, J2,3 = 11.3 Hz, J3,4 = 3.6 Hz, H-3B), 
5.49-5.45 (m, 3H, PhCH, H-1B, H-1A), 5.19 (d, 1H, CH2(Bn)), 5.11-5.00 
(m, 3H, CH2(Bn), H-2A), 4.85 (d, 1H, CH2(Bn)), 4.69 (m, 1H, H-2B), 4.39 
(d, 1H, J4,5 = 9.0 Hz, H-5A), 4.29-4.08 (m, 4H, H-4B, H-3A, H-4A, H-6aB), 
3.80 (d, 1H, J6a,6b = 12.0 Hz, H-6bB), 3.10 (s, 1H, H-5B), 2.68-2.37 (m, 4H, 
CH2(Lev)), 1.91 (s, 3H, CH3(Lev)); 13C-NMR (75 MHz, CDCl3) (for major 
anomer (α)): δ 206.3 (CO(Lev)), 171.9, 168.5, 165.9, 164.2, 163.5 (CO(Lev, 
NTCP, COOBn, Bz), 140.0, 139.8, 138.3, 137.7, 135.2 (Ar-C), 133.4 (Ar-
CH), 130.0-126.5 (Ar-C, Ar-CH), 101.0 (PhCH), 98.0 (C-1B), 90.7 (C-1A), 
77.8, 77.4 (C-3A, C-4A), 74.8 (CH2(Bn)), 73.2 (C-2A), 72.8 (C-4B), 70.5 
(C-5A), 68.9 (C-6B), 68.5 (C-3B), 67.5 (CH2(Bn)), 66.4 (C-5B), 52.1 (C-
2B), 37.9 (CH2(Lev)), 29.6 (CH3(Lev)), 28.2 (CH2(Lev)); 1H-NMR (300 
MHz, CDCl3) (for minor anomer (β)): δ 7.94 (m, 2H, Ar), 7.58-7.07 (m, 
18H, Ar), 5.71 (dd, 1H, J2,3 = 11.4 Hz, J3,4 = 3.6 Hz, H-3B), 5.49-5.45 (m, 
1H, PhCH), 5.39 (d, 1H, J1,2 = 8.4 Hz, H-1B), 5.21 (d, 1H, CH2(Bn)), 5.11-
5.00 (m, 3H, CH2(Bn), H-2A), 4.83 (d, 1H, CH2(Bn)), 4.72-4.66 (m, 2H, H-
1A, H-2B), 4.29-4.08 (m, 3H, H-4B, H-4A, H-6aB), 3.97-3.78 (m, 3H, H-
3A, H-5A, H-6bB), 3.12 (s, 1H, H-5B), 2.68-2.37 (m, 4H, CH2(Lev)), 1.91 
(s, 3H, CH3(Lev)); 13C-NMR (75 MHz, CDCl3) (selected data for minor 
anomer (β)): δ 101.0 (PhCH), 97.8 (C-1B), 96.3 (C-1A), 79.9 (C-3A), 77.8 
(C-4A), 75.4 (C-2A), 74.8 (CH2(Bn)), 74.7 (C-5A), 73.2(C-4B), 68.9 (C-
6B), 68.3 (C-3B), 67.7 (CH2(Bn)), 66.4 (C-5B), 52.0 (C-2B), 37.9 
(CH2(Lev)), 29.6 (CH3(Lev)), 28.2 (CH2(Lev)); HR MS: m/z: calcd for 
C53H45Cl4NO16Na: 1114.1390; found: 1114.1425 [M+Na]+. 
O-[Benzyl 2-O-benzoyl-3-O-benzyl-4-O-(4,6-O-benzylidene-2-deoxy-3-
O-levulinoyl-2-tetrachlorophthalimido-β-D-galactopyranosyl)-α,β-D-
glucopyranosyluronate] trichloroacetimidate (13): Trichloroacetonitrile 
(1.57 mL, 15.8 mmol) and K2CO3 (47 mg, 0.35 mmol) were added to 12 
(345 mg, 315 µmol) in dry CH2Cl2 (8 mL) under an argon atmosphere. 
After stirring at room temperature for 15 h, the mixture was filtered and 
concentrated in vacuo to give 13 (370 mg, 95%) as an α/β mixture (75:100). 
TLC (toluene-acetone 8:1) Rf 0.40; 1H-NMR (300 MHz, CDCl3) (for major 
anomer (β)): δ 8.53 (s, 1H, NH), 7.91 (m, 2H, Ar), 7.58-7.09 (m, 18H, Ar), 
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6.00 (d, 1H, J1,2 = 6.1 Hz, H-1A), 5.69 (dd, 1H, J2,3 = 11.3 Hz, J3,4 = 3.6 Hz, 
H-3B), 5.52-5.43 (m, 3H, PhCH, H-1B, H-2A), 5.19-4.87 (m, 4H, 
CH2(Bn)), 4.70 (m, 1H, H-2B), 4.48 (dd, 1H, J3,4 = 8.0 Hz, J4,5 = 9.8 Hz, H-
4A), 4.34-4.20 (m, 1H, H-4B), 4.16-4.08 (m, 2H, H-5A, H-6aB), 4.00 (dd, 
1H, J2,3 = 6.5 Hz, H-3A), 3.84 (d, 1H, J6a,6b = 11.5 Hz, H-6bB), 3.13 (s, 1H, 
H-5B), 2.69-2.32 (m, 4H, CH2(Lev)), 1.92 (s, 3H, CH3(Lev)); 13C-NMR (75 
MHz, CDCl3) (for major anomer (β)): δ 206.2 (CO(Lev)), 171.9, 167.4, 
164.9, 164.2, 163.4 (CO(Lev, NTCP, COOBn, Bz), 160.8 (C=NH), 140.0, 
139.8, 138.2, 137.7, 135.0 (Ar-C), 133.5 (Ar-CH), 129.9-126.4 (Ar-C, Ar-
CH), 100.9 (PhCH), 98.2 (C-1B), 95.5 (C-1A), 90.5 (CCl3), 80.5(C-3A), 
77.4 (C-4A), 74.4 (C-5A), 73.7 (CH2(Bn)), 72.7 (C-4B), 71.4 (C-2A), 68.9 
(C-6B), 68.5 (C-3B), 67.5 (CH2(Bn)), 66.5 (C-5B), 52.0 (C-2B), 37.9 
(CH2(Lev)), 29.6 (CH3(Lev)), 28.2 (CH2(Lev)); 1H-NMR (300 MHz, 
CDCl3) (for minor anomer (α)): δ 8.50 (s, 1H, NH), 7.91 (m, 2H, Ar), 7.58-
7.09 (m, 18H, Ar), 6.56 (d, 1H, J1,2 = 3.6 Hz, H-1A), 5.70 (dd, 1H, J2,3 = 
11.4 Hz, J3,4= 3.8 Hz, H-3B), 5.52-5.43 (m, 2H, PhCH, H-1B), 5.34 (dd, 1H, 
J2,3 = 9.3 Hz, H-2A), 5.21-4.82 (m, 4H, CH2(Bn)), 4.70 (m, 1H, H-2B), 
4.34-4.08 (m, 5H, H-3A, H-4A, H-5A, H-4B, H-6aB), 3.80 (d, 1H, J6a,6b = 
11.6 Hz, H-6bB), 3.11 (s, 1H, H-5B), 2.69-2.32 (m, 4H, CH2(Lev)), 1.92 (s, 
3H, CH3(Lev)); 13C-NMR (75 MHz, CDCl3) (selected data for minor 
anomer (α)): δ 160.4 (C=NH), 129.9-126.4 (Ar-C, Ar-CH), 100.9 (PhCH), 
98.4 (C-1B), 93.4 (C-1A), 79.9, 77.9, 75.0 (C-3A, C-4A, C-5A), 73.5 
(CH2(Bn)), 72.7 (C-4B), 71.9 (C-2A), 68.9 (C-6B), 68.5 (C-3B), 67.6 
(CH2(Bn)), 66.4 (C-5B), 52.1 (C-2B); HR MS: m/z: calcd for 
C55H45Cl7N2O16Na: 1257.0486; found: 1257.0470 [M+Na]+.  
Benzyl [N-Benzyloxycarbonyl-5-aminopentyl 2-O-benzoyl-3-O-benzyl-
4-O-(4,6-O-benzylidene-2-deoxy-3-O-levulinoyl-2-
tetrachlorophthalimido-β-D-galactopyranosyl)-β-D-glucopyranoside] 
uronate (14): Donor 13 (184 mg, 0.15 mmol) and benzyl N-(5-
hydroxypentyl) carbamate (107 mg, 0.45 mmol) were dissolved in dry 
CH2Cl2 (1 mL) in the presence of freshly activated 4Å molecular sieves. 
After stirring for 45 min at room temperature, TMSOTf (162 µL of a 0.092 
M solution in dry CH2Cl2) was added under an argon atmosphere. After 
stirring for 15 min, the reaction mixture was neutralized with Et3N and 
concentrated to dryness. The residue was purified by column 
chromatography (toluene-acetone 10:1) to afford 14 (130 mg, 67%). TLC 
(toluene-EtOAc 3:1) Rf 0.44; [α]20D –5º (c 1.0, CHCl3); 1H-NMR (300 MHz, 
CDCl3): δ 7.92 (m, 2H, Ar), 7.53 (m, 1H, Ar), 7.48-7.02 (m, 22H, Ar), 5.71 
(dd, 1H, J2,3 = 11.5 Hz, J3,4 = 3.5 Hz, H-3B), 5.46 (s, 1H, PhCH), 5.36 (d, 
1H, J1,2 = 8.4 Hz, H-1B), 5.21 (m, 2H, H-2A, CH2(Bn)), 5.05 (m, 3H, 
CH2(Z), CH2(Bn)), 4.94 (d, 1H, CH2(Bn)), 4.79 (d, 1H, CH2(Bn)), 4.68 (dd, 
1H, H-2B), 4.55 (bt, 1H, NH), 4.44 (d, 1H, J1,2 = 7.5 Hz, H-1A), 4.26 (bd, 
1H, H-4B), 4.24 (t, 1H, J3,4 = J4,5 = 9.5 Hz, H-4A), 4.13 (d, 1H, J6a,6b = 12.1 
Hz, H-6aB), 3.88-3.80 (m, 3H, H-3A, H-5A, H-6bB), 3.70, 3.30 (2m, 2H, 
CH2-O), 3.10 (bs, 1H, H-5B), 2.89 (m, 2H, CH2-N), 2.69-2.32 (m, 4H, 
CH2(Lev)), 1.92 (s, 3H, CH3(Lev)), 1.49-1.06 (m, 6H, (CH2)3); 13C-NMR 
(75 MHz, CDCl3): δ 206.3 (CO(Lev)), 171.9, 167.7, 165.1, 164.2, 163.5 
(CO(Lev, NTCP, COOBn, Bz)), 156.4 (CO(Z)), 140.0, 139.8, 138.4, 137.7, 
136.8 (Ar-C), 133.3 (Ar-CH), 129.9, 129.8, 129.4, 129.1, 128.7, 128.6, 
128.5, 128.4, 128.2, 127.9, 127.4, 127.3, 126.4 (Ar-C, Ar-CH), 101.4 
(C-1A), 100.9 (PhCH), 97.9 (C-1B), 80.4 (C-3A), 78.0 (C-4A), 74.7 (C-
5A), 74.3 (CH2(Bn)), 73.2 (C-2A), 72.7 (C-4B), 69.8 (CH2-O), 68.9 (C-6B), 
68.3 (C-3B), 67.5 (CH2(Bn)), 66.6 (CH2(Z)), 66.3 (C-5B), 52.1 (C-2B), 
40.9 (CH2-N), 37.9 (CH2(Lev)), 29.6 (CH2), 29.4 (CH3(Lev)), 28.9 (CH2), 
28.1 (CH2(Lev)), 23.1 (CH2); HR MS: m/z: calcd for C66H62Cl4N2O18Na: 
1333.2649; found: 1333.2604 [M+Na]+.  
Benzyl [N-Benzyloxycarbonyl-5-aminopentyl 2-O-benzoyl-3-O-benzyl-
4-O-(2-deoxy-3-O-levulinoyl-2-tetrachlorophthalimido-β-D-
galactopyranosyl)-β-D-glucopyranoside] uronate (17): TFA (100 µL) 
was added at 0ºC to a solution of 14 (25 mg, 19 µmol) in CH2Cl2 (1 mL). 
After stirring for 2 h at 0ºC, the solution was diluted with CH2Cl2 and 
washed with saturated NaHCO3 aqueous solution and brine. The organic 
layer was dried (MgSO4), filtered and concentrated in vacuo. The residue 
was purified by column chromatography (toluene-acetone 7:2) to afford 17 
(23 mg, 99%). TLC (toluene-acetone 7:2) Rf 0.14; [α]20D –12º (c 1.0, 
CHCl3); 1H-NMR (300 MHz, CDCl3): δ 7.97 (m, 2H, Ar), 7.55 (m, 1H, Ar), 
7.43-7.13 (m, 17H, Ar), 5.59 (dd, 1H, J2,3 = 11.3 Hz, J3,4 = 3.1 Hz, H-3B), 
5.28-5.13 (m, 4H, H-1B, H-2A, CH2(Bn)), 5.06 (m, 2H, CH2(Z)), 4.85 (d, 
1H, CH2(Bn)), 4.66-4.55 (m, 3H, CH2(Bn), H-2B, NH), 4.48 (d, 1H, J1,2 = 
7.4 Hz, H-1A), 4.25 (t, 1H, J3,4 = J4,5 = 9.3 Hz, H-4A), 4.13 (bd, 1H, H-4B), 
3.87 (d, 1H, H-5A), 3.82 (t, 1H, J2,3 = 8.9 Hz, H-3A), 3.73 (m, 1H, CH2-O), 
3.62 (m, 2H, H-6aB, H-6bB), 3.34 (m, 2H, CH2-O, H-5B), 2.91 (m, 2H, 
CH2-N), 2.66, 2.40 (2m, 4H, CH2(Lev)), 2.03 (s, 3H, CH3(Lev)), 1.49-1.11 
(m, 6H, (CH2)3); 13C-NMR (75 MHz, CDCl3): δ 207.4 (CO(Lev)), 171.8, 
167.6, 165.1, 164.1, 163.3 (CO(Lev, NTCP, COOBn, Bz)), 156.4 (CO(Z)), 
140.0, 139.8, 137.9, 136.8, 135.1 (Ar-C), 133.4 (Ar-CH), 129.8, 129.7, 
129.6, 128.7, 128.6, 128.5, 128.3, 128.2, 128.0, 127.6, 127.3 (Ar-C, Ar-
CH), 101.4 (C-1A), 97.0 (C-1B), 79.3 (C-3A), 76.9 (C-4A), 74.9 (C-5A), 
73.7 (C-5B), 73.5 (CH2(Bn)), 72.5 (C-2A), 70.1 (C-3B), 69.7 (CH2-O), 67.4 
(CH2(Bn)), 67.2 (C-4B), 66.5 (CH2(Z)), 62.7 (C-6B), 51.7 (C-2B), 40.8 
(CH2-N), 38.0 (CH2(Lev)), 29.5 (CH2, CH3(Lev)), 28.8 (CH2), 28.1 
(CH2(Lev)), 22.9 (CH2); HR MS: m/z: calcd for C59H58Cl4N2O18Na: 
1245.2336; found: 1245.2332 [M+Na]+. 
Benzyl [N-Benzyloxycarbonyl-5-aminopentyl 2-O-benzoyl-3-O-benzyl-
4-O-(2-deoxy-3-O-levulinoyl-4,6-di-O-sulfo-2-tetrachlorophthalimido-
β-D-galactopyranosyl)-β-D-glucopyranoside] uronate (18): Compound 
17 (13 mg, 11 µmol) and sulfur trioxide–trimethylamine complex (15 mg, 
0.11 mmol) were dissolved in dry DMF (1.0 mL) and heated at 100ºC for 
40 min using microwave radiation (28 W average power). The reaction 
vessel was cooled and Et3N (150 µL), MeOH (1 mL) and CH2Cl2 (1 mL) 
were added. The solution was layered on the top of a Sephadex LH 20 
chromatography column which was eluted with CH2Cl2-MeOH (1:1) to 
obtain 18 as triethylammonium salt (14 mg, 83%). TLC (CH2Cl2- MeOH 
9:2) Rf 0.40; 1H-NMR (300 MHz, CD3OD): δ 7.98 (m, 2H, Ar), 7.60 (m, 
1H, Ar), 7.50-7.05 (m, 17H, Ar), 5.77 (dd, 1H, J2,3 = 11.6 Hz, J3,4 = 3.3 Hz, 
H-3B), 5.35 (d, 1H, J1,2 = 8.3 Hz, H-1B), 5.29 (d, 1H, CH2(Bn)), 5.17 (d, 
1H, CH2(Bn)),  5.06 (t, 1H, J1,2 = 8.0 Hz, J2,3 = 8.7 Hz, H-2A), 5.02 (m, 2H, 
CH2(Z)), 4.96 (d, 1H, CH2(Bn)), 4.86 (bd, 1H, H-4B), 4.68 (d, 1H, H-1A), 
4.56 (m, 2H, CH2(Bn), H-2B), 4.45 (dd, 1H, J5,6a = 3.4 Hz, J6a,6b = 11.9 Hz, 
H-6aB), 4.22 (m, 2H, H-6bB, H-4A), 4.11 (m, 2H, H-5A, H-5B), 4.00 (t, 
1H, J3,4 = 9.2 Hz, H-3A), 3.69 (m, 1H, CH2-O), 3.42 (m, 1H, CH2-O), 3.19 
(q, 12H, Et3NH+), 2.82 (m, 3H, CH2-N, CH2(Lev)), 2.60 (dt, 1H, CH2(Lev)), 
2.39 (m, 2H, CH2(Lev)), 1.92 (s, 3H, CH3(Lev)), 1.44-1.08 (m, 24H, (CH2)3, 
Et3NH+); 13C-NMR (75 MHz, CD3OD) (Significant data from HSQC 
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experiment): δ 102.2 (C-1A), 97.8 (C-1B), 79.8 (C-3A), 77.8 (C-4A), 74.9 
(C-5A), 74.5 (C-5B), 74.2 (CH2(Bn)), 73.7 (C-2A), 72.7 (C-4B), 70.6 
(CH2-O), 68.5 (C-3B), 68.4 (C-6B), 68.1 (CH2(Bn)), 66.9 (CH2(Z)), 52.9 
(C-2B), 47.4 (Et3NH+), 41.3 (CH2-N), 38.1 (CH2(Lev)), 29.8 (CH2), 29.6 
(CH2), 29.1 (CH3(Lev)), 28.8 (CH2(Lev)), 23.5 (CH2), 8.7 (Et3NH+); ESI 
MS: m/z: calcd for C59H56Cl4N2O24S2Na: 1403.1; found: 1402.7 [M+Na]-; 
HR MS: m/z: calcd for C59H56Cl4N2O24S2: 690.0715; found: 690.0709 [M]-2. 
N-Benzyloxycarbonyl-5-aminopentyl 4-O-(2-acetamido-2-deoxy-4,6-di-
O-sulfo-β-D-galactopyranosyl)-3-O-benzyl-β-D-glucopyranosiduronic 
acid (21): H2O2 (30%, 0.52 mL) and an aqueous solution of LiOH (0.7 M, 
0.32 mL) were added at -5ºC to a solution of 18 (21 mg, 13 µmol) in THF 
(1.4 mL). After stirring for 20 h at room temperature, MeOH (1.4 mL) and 
an aqueous solution of NaOH (4 M, 0.33 mL) were added. After stirring for 
24 h at room temperature, the reaction mixture was neutralized with 
Amberlite IR-120 (H+) resin, filtered, and concentrated. The residue was 
dissolved in CH2Cl2/MeOH/Et3N (1.0 mL/1.0 mL/0.1 mL) and purified by 
Sephadex LH-20 chromatography (CH2Cl2-MeOH 1:1) to give compound 
19 as triethylammonium salt (16 mg, 86%). TLC (EtOAc:Py:H2O:AcOH 
9:5:3:1) Rf 0.27; 1H-NMR (300 MHz, CD3OD): δ 7.59-7.19 (m, 10H, Ar), 
5.06 (m, 3H, CH2(Z), CH2(Bn)), 4.79 (bd, 1H, H-4B), 4.72 (d, 1H, 
CH2(Bn)), 4.62 (d, 1H, J1,2 = 8.3 Hz, H-1B), 4.45 (dd, 1H, J5,6a = 3.9 Hz, 
J6a,6b = 11.8 Hz, H-6aB), 4.41 (d, 1H, J1,2 = 8.0 Hz, H-1A), 4.22 (m, 2H, H-
2B, H-6bB), 4.06 (bt, 1H, H-4A), 3.96 (m, 1H, H-5B), 3.86 (m, 1H, 
CH2-O), 3.77 (dd, 1H, J2,3 = 10.8 Hz, J3,4 = 2.9 Hz, H-3B), 3.58 (m, 3H, 
CH2-O, H-3A, H-5A), 3.37 (t, 1H, J2,3 = 8.0 Hz, H-2A), 3.19 (q, 24H, 
Et3NH+), 3.11 (m, 2H, CH2-N), 1.66-1.38 (3m, 6H, (CH2)3), 1.29 (t, 36H, 
Et3NH+); 13C-NMR (75 MHz, CD3OD) (Significant data from HSQC 
experiment): δ 129.5, 128.9, 128.7, 128.3 (Ar-CH), 104.0 (C-1A), 100.8 
(C-1B), 83.7 (C-3A), 78.9 (C-4A), 76.8 (C-4B), 75.4 (CH2(Bn)), 74.5 (C-
5B), 74.0 (C-2A), 72.8 (C-3B), 70.5 (CH2-O), 68.6 (C-6B), 67.0 (CH2(Z)), 
55.3 (C-2B), 47.6 (Et3NH+), 41.3 (CH2-N), 30.1, 30.0, 23.8 ((CH2)3), 8.9 
(Et3NH+); ESI MS: m/z: calcd for C40H43Cl4N2O22S2: 1107.1; found: 1106.7 
[M+3H]-.  
Ethylendiamine (76 µL, 1.1 mmol) was added under an argon atmosphere 
to a solution of 19 (16 mg, 11 µmol) in dry DMF (1.3 mL), and the reaction 
mixture was subjected to microwave radiation for 90 min at 100ºC. The 
reaction vessel was cooled under a stream of nitrogen and concentrated to 
dryness. The residue was purified by Sephadex LH-20 chromatography 
(CH2Cl2-MeOH 1:1) to give 20. TLC (EtOAc:Py:H2O:AcOH 9:5:3:1) Rf 
0.38; ESI MS: m/z: calcd for C32H42N2O19S2: 411.1; found: 410.8 [M+H]2-. 
Triethylamine (207 µL of a 0.18 M solution in dry MeOH) and acetic 
anhydride (5 µL, 0.05 mmol) were added to a cooled solution of 20 (11 
µmol) in dry MeOH (2.3 mL). After stirring for 2 h at 0ºC, additional 
triethylamine (207 µL of a 0.18 M solution in dry MeOH) and acetic 
anhydride (5 µL, 0.05 mmol) were added and the reaction was stirred for 1 
h at room temperature. The reaction mixture was purified by Sephadex LH-
20 chromatography (CH2Cl2-MeOH 1:1). The residue was converted into 
the sodium salt by elution from a column of Dowex 50WX4-Na+ with 
MeOH-H2O 9:1 to give 21 (7.9 mg, 75% from 19). TLC 
(EtOAc:Py:H2O:AcOH 9:5:3:1) Rf 0.28; 1H-NMR (500 MHz, CD3OD): δ 
7.54-7.19 (m, 10H, Ar), 5.04 (m, 3H, CH2(Z), CH2(Bn)), 4.78 (bs, 1H, 
H-4B), 4.68 (m, 2H, CH2(Bn), H-1B), 4.38 (dd, 1H, J5,6a = 5.0 Hz, J6a,6b = 
11.3 Hz, H-6aB), 4.28 (d, 1H, J1,2 = 7.3 Hz, H-1A), 4.16 (dd, 1H, J5,6b = 6.3 
Hz, H-6bB), 4.05 (t, 1H, J1,2 = J2,3 = 9.5 Hz, H-2B), 3.99 (t, 1H, J3,4 = J4,5 = 
9.1 Hz, H-4A), 3.96 (m, 1H, H-5B), 3.86 (m, 1H, CH2-O), 3.66 (m, 2H, H-
5A, H-3B), 3.52 (m, 1H, CH2-O), 3.44 (bt, 1H, H-3A), 3.38 (bt, 1H, H-2A), 
3.11 (t, 2H, CH2-N), 2.04 (s, 3H, NAc), 1.62, 1.51, 1.40 (3m, 6H, (CH2)3); 
13C-NMR (125.5 MHz, CD3OD) (Significant data from HSQC experiment): 
δ 104.1 (C-1A), 101.5 (C-1B), 83.8 (C-3A), 79.8 (C-4A), 78.0 (C-5A), 76.8 
(C-4B), 75.6 (CH2(Bn)), 74.0 (C-5B, C-2A), 73.5 (C-3B), 70.4 (CH2-O), 
67.8 (C-6B), 67.0 (CH2(Z)), 54.4 (C-2B), 41.5 (CH2-N), 30.4, 30.0, 23.8 
((CH2)3), 23.0 (NAc); ESI MS: m/z: calcd for C34H44N2O20S2: 432.1; found: 
431.8 [M+H]2-; HR MS: m/z: calcd for C34H44N2O20S2: 432.0969; found: 
432.0956 [M+H]2-.  
5-aminopentyl 4-O-(2-acetamido-2-deoxy-4,6-di-O-sulfo-β-D-
galactopyranosyl)-β-D-glucopyranosiduronic acid (15): A solution of 21 
(7.9 mg, 8.5 µmol, as sodium salt) in H2O/MeOH (2.7 mL/0.3 mL) was 
hydrogenated in the presence of Pd(OH)2. After 24 h, the suspension was 
filtered over Celite and concentrated. The residue was purified by Sephadex 
G-10 chromatography (H2O/MeOH 9:1) to give 15 as sodium salt after 
lyophilisation (6.0 mg, quantitative; 53% from 14, 6 steps, 90% average 
yield per step). 1H-NMR (500 MHz, D2O): δ 4.72 (bd, 1H, J3,4 = 2.1 Hz,  
H-4B), 4.58 (d, 1H, J1,2 = 7.6 Hz, H-1B), 4.47 (d, 1H, J1,2 = 8.1 Hz, H-1A), 
4.32 (dd, 1H, J5,6a = 3.3 Hz, J6a,6b = 11.3 Hz, H-6aB), 4.25 (dd, 1H, J5,6b = 
8.7 Hz, H-6bB), 4.12 (dd, 1H, H-5B), 3.94-3.87 (m, 3H, H-2B, H-3B, 
CH2-O), 3.77 (m, 3H, H-4A, H-5A, CH2-O), 3.62 (t, 1H, J2,3 = J3,4 = 9.2 Hz, 
H-3A), 3.35 (t, 1H, H-2A), 3.00 (t, 2H, CH2-N), 2.05 (s, 3H, NAc), 1.67, 
1.46 (2m, 6H, (CH2)3); 13C-NMR (125.5 MHz, D2O) (Significant data from 
HSQC experiment): δ 102.8 (C-1A), 102.2 (C-1B), 82.3 (C-4A), 77.2 
(C-5A), 76.0 (C-4B), 74.9 (C-3A), 73.1 (C-2A), 72.9 (C-5B), 70.6 (CH2-O), 
70.5 (C-3B), 68.3 (C-6B), 53.0 (C-2B), 39.9 (CH2-N), 28.6, 26.8 (CH2, 
CH2), 23.1 (NAc), 22.5 (CH2); ESI MS: m/z: calcd for C19H33N2O18S2: 
641.1; found: 640.8 [M+2H]-; HR MS: m/z: calcd for C19H33N2O18S2: 
641.1188; found: 641.1170 [M+2H]-. 
Benzyl [N-Benzyloxycarbonyl-5-aminopentyl 2-O-benzoyl-3-O-benzyl-
4-O-(2-deoxy-3-O-levulinoyl-6-O-sulfo-2-tetrachlorophthalimido-β-D-
galactopyranosyl)-β-D-glucopyranoside] uronate (22): Compound 17 (27 
mg, 22 µmol) and sulfur trioxide–trimethylamine complex (6.2 mg, 44 
µmol) were dissolved in dry DMF (3.0 mL) and heated at 50ºC for 30 min 
using microwave radiation (15 W average power). The reaction vessel was 
cooled and Et3N (150 µL), MeOH (1 mL) and CH2Cl2 (1 mL) were added. 
The solution was purified by Sephadex LH 20 chromatography (CH2Cl2-
MeOH 1:1) and silica gel column chromatography (CH2Cl2-MeOH 12:1 + 
1% Et3N) to afford 22 as triethylammonium salt (26 mg, 84%). TLC 
(CH2Cl2-MeOH 10:1) Rf 0.41; 1H-NMR (300 MHz, CD3OD): δ 7.97 (m, 
2H, Ar), 7.60 (m, 1H, Ar), 7.47 (m, 2H, Ar), 7.39-7.26 (m, 10H, Ar), 7.13-
7.03 (m, 5H, Ar), 5.66 (dd, 1H, J2,3 = 11.4 Hz, J3,4 = 3.2 Hz, H-3B), 5.42 (d, 
1H, J1,2 = 8.5 Hz, H-1B), 5.30 (d, 1H, CH2(Bn)), 5.14 (d, 1H, CH2(Bn)),  
5.08 (t, 1H, J1,2 = 7.8 Hz, J2,3 = 8.6 Hz, H-2A), 5.02 (m, 2H, CH2(Z)), 4.89 
(d, 1H, CH2(Bn)), 4.68 (d, 1H, H-1A), 4.59 (dd, 1H, H-2B), 4.55 (d, 1H, 
CH2(Bn)), 4.23-4.08 (m, 5H, H-4A, H-4B, H-5A, H-6aB, H-6bB), 3.99 (t, 
1H, H-3A), 3.81 (bt, 1H, H-5B), 3.69 (m, 1H, CH2-O), 3.40 (m, 1H, CH2-
O), 3.18 (q, 6H, Et3NH+), 2.82 (m, 2H, CH2-N), 2.65 (m, 2H, CH2(Lev)), 
2.38 (m, 2H, CH2(Lev)), 1.89 (s, 3H, CH3(Lev)), 1.44-1.10 (m, 15H, (CH2)3, 
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Et3NH+); 13C-NMR (75 MHz, CD3OD) (Significant data from HSQC 
experiment): δ 134.4, 130.6, 129.4, 129.2, 129.0, 128.6, 128.5 (Ar-CH), 
102.2 (C-1A), 97.9 (C-1B), 79.8 (C-3A), 77.7 (C-4A, C-5A), 75.3 (C-4B), 
73.8 (C-5B, CH2(Bn)), 73.7 (C-2A), 70.8 (C-3B), 70.6 (CH2-O), 68.1 
(CH2(Bn)), 67.1 (CH2(Z)), 66.2 (C-6B), 53.1 (C-2B), 47.7 (Et3NH+), 41.2 
(CH2-N), 38.2 (CH2(Lev)), 30.3 (CH2), 29.9 (CH2), 29.1 (CH3(Lev)), 28.7 
(CH2(Lev)), 23.8 (CH2), 9.0 (Et3NH+); ESI MS: m/z: calcd for 
C59H57Cl4N2O21S: 1301.2; found: 1301.0 [M]-; HR MS: m/z: calcd for 
C59H57Cl4N2O21S: 1301.1934; found: 1301.2029 [M]-.   
N-Benzyloxycarbonyl-5-aminopentyl 4-O-(2-acetamido-2-deoxy-6-O-
sulfo-β-D-galactopyranosyl)-3-O-benzyl-β-D-glucopyranosiduronic acid 
(25): H2O2 (30%, 0.73 mL) and an aqueous solution of LiOH (0.7 M, 0.45 
mL) were added at -5ºC to a solution of 22 (26 mg, 18 µmol) in THF (2.0 
mL). After stirring for 20 h at room temperature, MeOH (2.0 mL) and an 
aqueous solution of NaOH (4 M, 0.46 mL) were added. After stirring for 24 
h at room temperature, the reaction mixture was neutralized with Amberlite 
IR-120 (H+) resin, filtered, and concentrated. The residue was dissolved in 
CH2Cl2/MeOH/Et3N (1.0 mL/1.0 mL/0.1 mL) and purified by Sephadex 
LH-20 chromatography (CH2Cl2-MeOH 1:1) to give compound 23 as 
triethylammonium salt (22 mg, 89%). TLC (EtOAc:Py:H2O:AcOH 9:5:3:1) 
Rf 0.34; 1H-NMR (300 MHz, CD3OD): δ 7.54 (m, 2H, Ar), 7.35-7.20 (m, 
8H, Ar), 5.06 (m, 2H, CH2(Z)), 5.04 (d, 1H, CH2(Bn)), 4.72 (d, 1H, 
CH2(Bn)), 4.68 (d, 1H, J1,2 = 8.8 Hz, H-1B), 4.36 (d, 1H, J1,2 = 7.6 Hz, H-
1A), 4.29 (dd, 1H, J5,6a = 7.4 Hz, J6a,6b = 10.5 Hz, H-6aB), 4.23 (bt, 1H, H-
2B), 4.15 (dd, 1H, J5,6b = 5.8 Hz, H-6bB), 4.07 (t, 1H, J3,4 = J4,5 = 8.4 Hz, 
H-4A), 3.99-3.94 (m, 2H, H-4B, H-5A), 3.85 (m, 1H, CH2-O), 3.76 (m, 1H, 
H-5B), 3.67 (m, 1H, H-3B), 3.54 (m, 2H, CH2-O, H-3A), 3.38 (t, 1H, J2,3 = 
8.0 Hz, H-2A), 3.18 (q, 18H, Et3NH+), 3.11 (m, 2H, CH2-N), 1.66-1.35 (3m, 
6H, (CH2)3), 1.29 (t, 27H, Et3NH+); 13C-NMR (75 MHz, CD3OD) 
(Significant data from HSQC experiment): δ 129.4, 128.9, 128.4 (Ar-CH), 
103.9 (C-1A), 100.7 (C-1B), 83.8 (C-3A), 78.7 (C-4A), 77.0 (C-5A), 75.4 
(CH2(Bn)), 74.6 (C-5B), 74.2 (C-2A), 74.0 (C-3B), 70.6 (CH2-O), 68.5 (C-
4B), 67.1 (CH2(Z)), 66.7 (C-6B), 55.0 (C-2B), 47.4 (Et3NH+), 41.5 (CH2-N), 
30.3, 30.1, 23.8 ((CH2)3), 8.9 (Et3NH+); ESI MS: m/z: calcd for 
C40H42Cl4KN2O19S: 1065.0; found: 1065.0 [M+H+K]-. 
Ethylendiamine (111 µL, 1.65 mmol) was added under an argon 
atmosphere to a solution of 23 (22 mg, 16 µmol) in dry DMF (1.0 mL), and 
the reaction mixture was subjected to microwave radiation for 90 min at 
100ºC. The reaction vessel was cooled and concentrated to dryness. The 
residue was purified by Sephadex LH-20 chromatography (CH2Cl2-MeOH 
1:1) to give 24. TLC (EtOAc:Py:H2O:AcOH 12:5:3:1) Rf 0.23; ESI MS: 
m/z: calcd for C32H43N2O16S: 743.2; found: 743.2 [M+H]-. 
Triethylamine (150 µL of a 0.36 M solution in dry MeOH) and acetic 
anhydride (7.8 µL, 83 µmol) were added to a cooled solution of 24 (16 
µmol) in dry MeOH (1.5 mL). After stirring for 3 h at room temperature, 
additional Et3N (0.2 mL) was added and the reaction mixture was purified 
by Sephadex LH-20 chromatography (CH2Cl2-MeOH 1:1). The residue was 
converted into the sodium salt by elution from a column of Dowex 50WX4-
Na+ with MeOH-H2O 9:1 to give 25 (12 mg, 88% from 23; 2 steps). TLC 
(EtOAc:Py:H2O:AcOH 12:5:3:1, two elutions) Rf 0.41; 1H-NMR (400 
MHz, CD3OD): δ 7.50-7.20 (m, 10H, Ar), 5.06 (s, 2H, CH2(Z)), 5.02 (d, 1H, 
CH2(Bn)), 4.69 (d, 1H, CH2(Bn)), 4.62 (d, 1H, J1,2 = 8.3 Hz, H-1B), 4.28 (d, 
1H, J1,2 = 6.9 Hz, H-1A), 4.25 (dd, 1H, J5,6a = 8.2 Hz, J6a,6b = 10.2 Hz, H-
6aB), 4.10 (dd, 1H, J5,6b = 5.4 Hz, H-6bB), 4.03-3.93 (m, 2H, H-2B, H-4A), 
3.91 (bs, 1H, H-4B), 3.86 (m, 1H, CH2-O), 3.74-3.65 (m, 2H, H-5B, H-5A), 
3.52 (m, 2H, H-3B, CH2-O), 3.44 (t, 1H, J2,3 = J3,4 = 8.9 Hz, H-3A), 3.39 (t, 
1H, H-2A), 3.11 (t, 2H, CH2-N), 2.06 (s, 3H, NAc), 1.62, 1.51, 1.41 (3m, 
6H, (CH2)3); 13C-NMR (100 MHz, CD3OD) (Significant data from HSQC 
experiment): δ 128.9-128.1 (Ar-CH), 103.9 (C-1A), 101.2 (C-1B), 83.8 (C-
3A), 79.7 (C-4A), 77.7 (C-5A), 75.2 (CH2(Bn)), 74.5 (C-3B), 73.9 (C-2A), 
73.8 (C-5B), 70.2 (CH2-O), 68.2 (C-4B), 66.9 (CH2(Z)), 66.2 (C-6B), 54.4 
(C-2B), 41.3 (CH2-N), 30.1, 29.8, 23.6 ((CH2)3), 22.6 (NAc); ESI MS: m/z: 
calcd for C34H45N2O17S: 785.2; found: 785.1 [M+H]-; HR MS: m/z: calcd 
for C34H44N2O17S: 392.1185; found: 392.1180 [M]-2. 
5-aminopentyl 4-O-(2-acetamido-2-deoxy-6-O-sulfo-β-D-
galactopyranosyl)-β-D-glucopyranosiduronic acid (16): A solution of 25 
(10 mg, 12 µmol, as sodium salt) in H2O/MeOH (3.6 mL/0.4 mL) was 
hydrogenated in the presence of Pd(OH)2. After 24 h, the suspension was 
filtered over Celite and concentrated. The residue was purified by Sephadex 
G-10 chromatography (H2O/MeOH 9:1) to give 16 as sodium salt after 
lyophilisation (7.4 mg, quantitative; 66 % from 17, 5 steps, 92% average 
yield per step). 1H-NMR (500 MHz, D2O): δ 4.53 (d, 1H, J1,2 = 8.5 Hz, H-
1B), 4.48 (d, 1H, J1,2 = 8.1 Hz, H-1A), 4.25 (m, 2H, H-6aB, H-6bB), 4.00 
(m, 2H, H-4B, H-5B), 3.92 (m, 2H, H-2B, CH2-O), 3.74 (m, 4H, H-3B, H-
4A, H-5A, CH2-O), 3.63 (t, 1H, J2,3 = J3,4 = 8.7 Hz, H-3A), 3.36 (t, 1H, 
H-2A), 3.00 (t, 2H, CH2-N), 2.06 (s, 3H, NAc), 1.68, 1.47 (2m, 6H, 
(CH2)3); 13C-NMR (125.5 MHz, D2O) (Significant data from HSQC 
experiment): δ 102.7 (C-1A), 102.0 (C-1B), 81.6 (C-4A), 77.1 (C-5A), 74.6 
(C-3A), 73.2 (C-5B), 73.1 (C-2A), 71.2 (C-3B), 70.6 (CH2-O), 67.9 (C-4B), 
67.6 (C-6B), 52.5 (C-2B), 39.8 (CH2-N), 28.5, 26.9 (CH2, CH2), 23.0 (NAc), 
22.4 (CH2); ESI MS: m/z: calcd for C19H33N2O15S: 561.1613; found: 561.0 
[M+H]-; HR MS: m/z: calcd for C19H33N2O15S: 561.1619; found: 561.1599 
[M+H]-. 
4-Methoxyphenyl 3-O-(benzyl 2-O-benzoyl-3-O-benzyl-4-O-levulinoyl-
β-D-glucopyranosyluronate)-2-deoxy-4,6-di-O-levulinoyl-2-
trifluoroacetamido-β-D-galactopyranoside (29): An excess of (HF)n·Py 
(5.5 mL) was added at 0°C under an argon atmosphere to a solution of 28 
(1.23 g, 1.14 mmol) in dry THF (25 mL). After 24 h at 0ºC, the mixture 
was diluted with CH2Cl2 and washed with H2O and saturated NaHCO3 
solution until neutral pH. The organic layer was dried (MgSO4), filtered and 
concentrated in vacuo to give the corresponding diol that was used for the 
next step without further purification [TLC (toluene-EtOAc 1:4) Rf 0.46]. 
LevOH (2.32 mL, 22.8 mmol) was added at 0ºC to a solution of 1,3-
dicyclohexylcarbodiimide (2.35 g, 11.4 mmol) in CH2Cl2 (20 mL). After 
stirring for 5 min at room temperature, the mixture was cooled, filtered and 
concentrated to give quantitatively levulinic anhydride (Lev2O, 11.4 mmol). 
A solution of the diol (1.14 mmol) in dry Py (30 mL) was added under an 
argon atmosphere to a flask containing Lev2O (11.4 mmol) and DMAP 
(140 mg, 1.14 mmol). After stirring for 5 h at room temperature, the 
reaction mixture was diluted with CH2Cl2 and washed with 1M HCl 
aqueous solution, saturated NaHCO3 aqueous solution and H2O. The 
organic layers were dried (MgSO4), filtered and concentrated in vacuo. The 
residue was purified by column chromatography (toluene-EtOAc 2:1) to 
afford 29 (950 mg, 83%). TLC (toluene-EtOAc 2:1) Rf 0.37; [α]20D +20º (c 
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1.0, CHCl3); 1H-NMR (500 MHz, CDCl3):  7.94 (m, 2H, Ar), 7.59 (m, 1H, 
Ar), 7.44 (m, 2H, Ar), 7.39-7.30 (m, 5H, Ar), 7.13-7.07 (m, 5H, Ar), 6.89 
(m, 2H, Ar), 6.77 (m, 2H, Ar), 6.69 (bs, 1H, NH), 5.47 (d, 1H, J3,4 = 2.6 Hz, 
H-4A), 5.32 (pt (pseudotriplet), 1H, H-4B), 5.28 (pt, 1H, H-2B), 5.19-5.11 
(m, 3H, H-1A and CH2(Bn)), 4.79 (d, 1H, J1,2 = 7.5 Hz, H-1B), 4.61-4.52 
(m, 3H, H-3A and CH2(Bn)), 4.15-4.09 (m, 2H, 2 x H-6A), 4.07 (d, 1H, J4,5 
= 9.6 Hz, H-5B), 3.89-3.80 (m, 3H, H-5A, H-3B and H-2A), 3.75 (s, 3H, 
OCH3), 2.80-2.20 (m, 12H, 3 x OCO(CH2)2), 2.15 (s, 3H, COCH3), 2.14 (s, 
3H, COCH3), 2.10 (s, 3H, COCH3); 13C-NMR (125 MHz, CDCl3):  206.84 
(CO(Lev)), 206.81 (CO(Lev)), 206.1 (CO(Lev)), 172.3 (CO), 171.5 (CO), 
171.2 (CO), 166.9 (CO), 165.0 (CO), 157.6 (q, JC,F = 38.7 Hz, COCF3), 
155.9 (Ar), 151.0 (Ar), 137.4 – 114.3 (Ar-C and Ar-CH), 115.5 (q, JC,F = 
289.0 Hz, COCF3), 100.1 (C-1B), 98.9 (C-1A), 79.2 (C-3B), 74.2 
(CH2(Bn)), 73.2 (C-3A), 72.8 (C-5B), 72.6 (C-2B), 71.6 (C-5A), 70.8 (C-
4B), 68.7 (C-4A), 67.9 (CH2(Bn)), 62.3 (C-6A), 55.7 (OCH3), 54.6 (C-2A), 
38.2 (OCO(CH2)2), 38.0 (OCO(CH2)2), 37.7 (OCO(CH2)2), 29.9 (COCH3), 
29.8 (2 x COCH3), 28.0 (OCO(CH2)2), 27.9 (OCO(CH2)2), 27.8 
(OCO(CH2)2); HR MS: m/z: calcd for C57H60F3NNaO20: 1158.3558; found: 
1158.3596 [M+Na]+.  
3-O-(Benzyl 2-O-benzoyl-3-O-benzyl-4-O-levulinoyl-β-D-
glucopyranosyluronate)-2-deoxy-4,6-di-O-levulinoyl-2-
trifluoroacetamido-α,β-D-galactopyranose (30): CAN (7.6 mL of a 0.44 
M solution in H2O) was added to a solution of 29 (950 mg, 0.84 mmol) in 
CH2Cl2/MeCN (1:2; 22.8 mL), and the mixture was vigorously stirred for 1 
h at room temperature. It was then diluted with EtOAc, washed with H2O, 
saturated aqueous NaHCO3 and H2O. The organic phase was dried 
(MgSO4), filtered and concentrated to dryness. The residue was purified by 
column chromatography (toluene-acetone 3:1) to afford 30 (695 mg, 81%) 
as a mixture of α/β anomers. TLC (toluene-acetone 3:2) Rf 0.44 and 0.31; 
1H-NMR (500 MHz, CDCl3) (data for α anomer):  7.94 (m, 2H, Ar), 7.57 
(m, 1H, Ar), 7.44-7.32 (m, 7H, Ar), 7.15-7.05 (m, 5H, Ar), 6.69 (d, 1H, 
J2,NH = 8.7 Hz, NH), 5.39 (d, 1H, J3,4 = 2.3 Hz, H-4A), 5.31-5.25 (m, 3H, H-
1A, H-2B and H-4B), 5.19-5.11 (2d, 2H, Jgem = 11.9 Hz, CH2(Bn)), 4.81 (d, 
1H, J1,2 = 7.7 Hz, H-1B), 4.55 (2d, 2H, Jgem = 11.6 Hz, CH2(Bn)), 4.40-4.32 
(m, 2H, H-2A and H-5A), 4.27-4.20 (m, 2H, H-6aA and H-3A), 4.05 (d, 1H, 
J4,5 = 9.7 Hz, H-5B), 3.94 (dd, 1H, J5,6b = 8.8 Hz, J6a,6b = 11.4 Hz, H-6bA), 
3.82 (pt, 1H, H-3B), 2.84-2.21 (m, 12H, 3 x OCO(CH2)2), 2.16 (s, 3H, 
COCH3), 2.10 (s, 3H, COCH3), 2.09 (s, 3H, COCH3); 13C-NMR (125 MHz, 
CDCl3) (data for α anomer)  208.8 (CO(Lev)), 206.9 (CO(Lev)), 206.0 
(CO(Lev)), 172.2 (CO), 171.8 (CO), 171.2 (CO), 166.8 (CO), 165.0 (CO), 
157.1 (q, COCF3), 137.3-127.8 (Ar-C and Ar-CH), 115.7 (q, COCF3), 99.6 
(C-1B), 91.4 (C-1A), 79.3 (C-3B), 74.2 (CH2(Bn)), 73.0 (C-5B), 72.2 (C-
2B), 72.0 (C-3A), 71.0 (C-4B),68.9 (C-4A), 68.0 (CH2(Bn)), 67.0 (C-5A), 
63.0 (C-6A), 50.1 (C-2A), 38.5 (OCO(CH2)2), 38.1 (OCO(CH2)2), 37.7 
(OCO(CH2)2), 30.0 (COCH3), 29.9 (COCH3), 29.8 (COCH3), 28.3 
(OCO(CH2)2), 28.0 (OCO(CH2)2), 27.7 (OCO(CH2)2); HR MS: m/z: calcd 
for C50H54NO19NaF3: 1052.3140; found: 1052.3175 [M+Na]+.   
O-[3-O-(Benzyl 2-O-benzoyl-3-O-benzyl-4-O-levulinoyl-β-D-
glucopyranosyluronate)-2-deoxy-4,6-di-O-levulinoyl-2-
trifluoroacetamido-α,β-D-galactopyranosyl] trichloroacetimidate (31): 
Compound 30 (120 mg, 0.11 mmol) was dissolved in dry CH2Cl2 (3 mL) 
and Cl3CCN (234 μL, 2.3 mmol) and DBU (261 μL of a 0.066 M solution 
in CH2Cl2) were added. After stirring at room temperature for 5 h, the 
mixture was concentrated in vacuo. Flash chromatography on silica gel 
(toluene-acetone 5:1 + 1% Et3N) afforded 31 (95 mg, 70%) as an α/β 
mixture. TLC (toluene-acetone 3:2) Rf 0.65 and 0.48; 1H-NMR (500 MHz, 
CDCl3) (data for α anomer):  8.71 (s, 1H, NH(TCA)), 7.96 (m, 2H, Ar), 
7.59 (m, 1H, Ar), 7.44 (m, 2H, Ar), 7.37 (m, 5H, Ar), 7.13-7.05 (m, 5H, Ar), 
7.00 (br d, J NH,2 = 7.3 Hz, 1H, NH(TFA)), 6.54 (d, 1H, J 1,2 = 3.4 Hz, 1H, 
H-1A), 5.55 (br d, 1H, H-4A), 5.35 (pt, 1H, H-2B), 5.23 (pt, 1H, H-4B), 
5.18-5.06 (2d, 2H, Jgem = 12.1 Hz, CH2(Bn)), 4.93 (d, 1H, J 1,2 = 7.9 Hz, H-
1B), 4.62-4.51 (m, 3H, H-2A and CH2(Bn)), 4.35 (dd, 1H, J 3,4 = 2.9 Hz, J 
2,3  = 11.0 Hz, H-3A), 4.28 (m, 1H, H-5A), 4.12-4.04 (m, 3H, H-5B and 2 x 
H-6A), 3.85 (pt, 1H, H-3B), 2.74-2.16 (m, 12H, 3OCO(CH2)2), 2.14 (s, 3H, 
COCH3), 2.10 (s, 3H, COCH3), 2.03 (s, 3H, COCH3).  
4-Methoxyphenyl O-(benzyl 2-O-benzoyl-3-O-benzyl-4-O-levulinoyl-β-
D-glucopyranosyluronate)-(1→3)-O-(2-deoxy-4,6-di-O-levulinoyl-2-
trifluoroacetamido-β-D-galactopyranosyl)-(1→4)-O-(benzyl 2-O-
benzoyl-3-O-benzyl-β-D-glucopyranosyluronate)-(1→3)-2-deoxy-4,6-O-
di-tert-butylsilylene-2-trifluoroacetamido-β-D-galactopyranoside (33): 
Donor 31 (143 mg, 0.12 mmol) and aceptor 32 (67 mg, 0.07 mmol) were 
coevaporated with toluene, concentrated in vacuo and dissolved in dry 
CH2Cl2 (3 mL) in the presence of freshly activated 4Å molecular sieves. 
After stirring for 10 min at 0 ºC, TMSOTf (264 µL of a 0.09 M solution in 
dry CH2Cl2) was added under an argon atmosphere. After stirring for 30 
min at 0ºC, the reaction mixture was neutralized with Et3N, filtered, and 
concentrated to dryness. The residue was purified by column 
chromatography (toluene-acetone 5:1) to afford 33 (97 mg, 71%). TLC 
(toluene-EtOAc 2:1) Rf 0.34; [α]20D +11º (c 1.0, CHCl3); 1H-NMR (500 
MHz, CDCl3):  7.96 (m, 2H, Ar), 7.91 (m, 2H, Ar), 7.57 (m, 2H, Ar), 
7.46-7.29 (m, 14H, Ar), 7.15-7.08 (m, 10H, Ar), 6.90 (m, 2H, Ar), 6.84 (d, 
1H, J2,NH = 6.9 Hz, NH), 6.78 (m, 2H, Ar), 6.52 (d, 1H, J2,NH = 8.7 Hz, NH), 
5.37-5.33 (m, 2H, H-1A and H-4D), 5.27-5.15 (m, 8H, H-1B, H-2B, H-4C, 
H-2D and 2 x CH2(Bn)), 4.78 (d, 1H, Jgem = 11.1 Hz, CH2(Bn)), 4.73 (d, 1H, 
J1,2 = 7.4 Hz, H-1D), 4.61-4.52 (m, 3H, H-4A and CH2(Bn)), 4.46 (d, 1H, 
Jgem = 11.1 Hz, CH2(Bn)), 4.33 (dd, 1H, J2,3 = 11.1 Hz, J3,4 = 1.9 Hz, H-3A), 
4.15-4.08 (m, 3H, H-1C, H-5D and H-6A), 4.05-4.02 (m, 2H, H-4B and H-
6A), 3.96-3.81 (m, 6H, H-2A, H-2C, 2 x H-6C H-5B and H-3D), 3.75 (s, 
3H, OCH3), 3.69 (m, 1H, H-3C), 3.63 (m, 1H, H-3B), 3.34 (m, 2H, H-5A 
and H-5C), 2.75-2.21 (m, 12H, 3 x OCO(CH2)2), 2.18 (s, 3H, COCH3), 2.11 
(s, 3H, COCH3), 2.07 (s, 3H, COCH3), 1.04 (s, 9H, C(CH3)3), 0.99 (s, 9H, 
C(CH3)3); 13C-NMR (125 MHz, CDCl3):  207.1 (CO(Lev)), 206.6 
(CO(Lev)), 206.0 (CO(Lev)), 172.2 (CO), 171.4 (CO), 171.2 (CO), 168.6-
164.9 (4 x CO), 157.6 (2q, 2 x COCF3), 156.0-114.5 (Ar-C and Ar-CH), 
117.9 (2q, 2 x COCF3), 100.2 (C-1B), 99.8, 99.7 (C-1C and C-1D), 99.3 
(C-1A), 80.1 (C-3B), 79.2 (C-3D), 77.8 (C-4B), 75.4 (C-3A), 75.1 
(CH2(Bn)), 74.3, 74.2, 74.1, 73.2, 73.0 (C-3C, C-5B, CH2(Bn), C-4A, C-
5D), 72.5, 72.4 (2C: C-2B or C-4C or C-2D or CH2(Bn)), 71.4, 71.1 (C-5A 
and C-5C), 70.9 (C-4D), 68.2, 68.1, 67.9 (3C: CH2(Bn) or C-2B or C-4C or 
C-2D), 67.0 (C-6A), 61.5 (C-6C), 55.7 (OCH3),  54.0, 53.0 (C-2A and C-
2C), 38.1 (OCO(CH2)2), 38.0 (OCO(CH2)2), 37.7 (OCO(CH2)2), 29.9 
(COCH3), 29.8 (COCH3), 29.7 (COCH3), 28.1 (OCO(CH2)2), 27.9 
(OCO(CH2)2), 27.7 (OCO(CH2)2), 27.6, 27.5, 27.5 (C(CH3)3), 23.3, 20.8 
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(C(CH3)3); HR MS: m/z: calcd for C100H110N2O32F6NaSi: 2015.6607; found: 
2015.6607 [M+Na]+.  
4-Methoxyphenyl O-(3-O-benzyl-2,4-di-O-sulfo-β-D-
glucopyranosyluronic acid)-(1→3)-O-(2-acetamido-2-deoxy-4,6-di-O-
sulfo-β-D-galactopyranosyl)-(1→4)-O-(3-O-benzyl-2-O-sulfo-β-D-
glucopyranosyluronic acid)-(1→3)-2-acetamido-2-deoxy-4,6-di-O-sulfo-
β-D-galactopyranoside (37): An excess of (HF)n·Py (102 µL, 3.8 mmol) 
was added at 0 ºC under an argon atmosphere to a solution of 33 (39 mg, 
0.02 mmol) in dry THF (1.0 mL). After 24 h at 0 ºC, the mixture was 
diluted with CH2Cl2 and washed with H2O and saturated NaHCO3 solution 
until neutral pH. The organic layer was dried (MgSO4), filtered and 
concentrated in vacuo. The residue was purified by column 
chromatography (toluene-EtOAc 2:3) to afford 34 (27 mg, 75%). TLC 
(toluene-EtOAc 1:2) Rf 0.36; 1H-NMR (400 MHz, CDCl3):  7.96 (m, 2H, 
Ar), 7.86 (m, 2H, Ar), 7.56 (m, 2H, Ar), 7.46-7.33 (m, 14H, Ar), 7.13-7.06 
(m, 10H, Ar), 6.86 (m, 2H, Ar), 6.74 (m, 2H, Ar), 5.34-5.11 (m, 9H, H-4D, 
H-2D, H-1A, H2B, H-4C and CH2(Bn)), 4.75 (m, 3H, H-1B, H-1D and 
CH2(Bn)), 4.60-4.49 (m, 4H, H-1C and CH2(Bn)), 4.38 (bs, 1H, H-3A), 
4.15 (bs, 1H, H-4B), 4.08-3.97 (m, 4H, H-4A, H-5D, H-5B and H-3C), 3.90 
(m, 3H, H-2C and 2 x H-6A or C), 3.82 (m, 3H, H-2A, H-3D and H-6A or 
C), 3.72 (m, 4H, H-3B and OCH3), 3.56 (m, 3H, H-5A, H-5C and H6A or 
C), 2.74-2.17 (m, 12H, 3x OCO(CH2)2), 2.12 (s, 3H, COCH3), 2.10 (s, 3H, 
COCH3), 2.06 (s, 3H, COCH3); 13C-NMR (100 MHz, CDCl3) (selected data 
from HSQC experiment):  100.1 (C-1B), 99.7 (C-1D), 99.6 (C-1C), 98.7 
(C-1A), 79.3 (C-3B), 79.1 (C-3D), 77.5 (C-3A), 77.3 (C-4B), 74.5 
(CH2(Bn)), 74.1 (CH2(Bn)), 74.1 (C-5B or 5D), 74.0 (C-5A or 5C), 73.9 
(C-3C), 72.7 (C-5B or 5D), 72.4 (C-2B, C4C), 71.0 (C-5A or 5C), 70.7 (C-
4D), 68.3 (C-4A), 68.0 (C-2D, 2 x CH2(Bn)), 62.6 (C-6A or C), 61.7 (C-6A 
or C), 55.7 (COCH3),  54.1 (C-2A), 53.2 (C-2C); HR MS: m/z: calcd for 
C92H94F6N2Na2O32: 949.2739; found: 949.2735 [M+2Na]2+. 
H2O2 (30%, 0.26 mL) and a solution of LiOH (0.7 M, 0.16 mL) were added 
at -5 ºC  to a solution of 34 (12 mg, 6.5 µmol) in THF (1.0 mL). After 
stirring for 24 h at room temperature, MeOH (1 mL) and a solution of 
NaOH (4 M, 0.33 mL) were added. After stirring for 3 days at room 
temperature, the reaction was neutralized with Amberlite IR-120 (H+) resin, 
filtered and concentrated to give 35. ESI MS: m/z: calcd for 
C45H56N2NaO22: 999.3; found: 999.4 [M+Na]-.  
Et3N (12 µL, 85 µmol) and Ac2O (12 µL, 129 µmol) were added to a cooled 
(0 ºC) solution of 35 (6.5 µmol) in dry MeOH (2.0 mL). After stirring for 3 
h at room temperature, triethylamine (0.3 mL) was added and the mixture 
was coevaporated with toluene and methanol. The residue was purified by 
Sephadex LH-20 chromatography (MeOH:CH2Cl2 1:1) to give 36 as 
triethylammonium salt. The sodium salt of 36 (6.2 mg, 90%) was obtained 
by treatment with Amberlite IR-120 (H+) resin in MeOH (pH ~ 3), followed 
by filtration, treatment with 0.04 M NaOH (pH ~ 7) and concentration. 1H-
NMR (500 MHz, MeOD, data for sodium salt):  7.58 (m, 2H, Ar), 7.44 (m, 
2H, Ar), 7.34-7.20 (m, 6H, Ar), 6.98 (m, 2H, Ar), 6.82 (m, 2H, Ar), 5.05 (d, 
1H, Jgem = 10.3 Hz, CH2(Bn)), 4.93 (d, 1H, J1,2 = 8.5 Hz, H-1A), 4.88 (m, 
2H, CH2(Bn)), 4.72 (d, 1H, Jgem = 10.3 Hz, CH2(Bn)), 4.62 (d, 1H, J1,2 = 8.5 
Hz, H-1C), 4.43 (m, 2H, H-1B and H-1D), 4.27 (dd, 1H, J1,2 = 8.5 Hz, J2,3 = 
10.7 Hz, H-2A), 4.19-4.12 (m, 3H, H-2C, H-4C and H-4A), 3.96 (m, 1H, 
H-4B), 3.86-3.76 (m, 4H, H-3A and 3 x H-6A or C), 3.74 (s, 3H, OCH3), 
3.72-3.56 (m, 6H, H-5B, H-6A or C, H-3C, H-5A or C, H-4D and H-5D), 
3.51 (m, 1H, H-5A or C), 3.46 (m, 2H, H-2B and H-3B), 3.41 (m, 2H, H-
2D and H-3D), 2.05 (s, 3H, NHCOCH3), 2.05 (s, 3H, NHCOCH3); 
13C-NMR (100 MHz, MeOD) (selected data from HSQC experiment):  
128.5-113.7 (Ar), 104.2 (C-1B and C-1D), 100.6 (C-1A), 100.0 (C-1C), 
84.1 (C-3D), 82.6 (C-3C), 82.5 (C-3B), 80.6 (C-3A), 77.6 (C-4B), 76.4 (C-
5B), 75.8 (C-5A or C), 75.2 (2C: C-4D or C-5D or C-5A or C), 75.0 
(CH2(Bn)), 74.0 (CH2(Bn)), 73.0 (C-2D), 72.7 (C-2B), 72.0 (C-4D or C-5D 
or C-5A or C), 67.6 (C-4A and C-4C), 61.1 (C-6A and C-6C), 54.4 
(COCH3), 51.5 (C-2C), 51.2 (C-2A), 22.1 (NHCOCH3), 21.6 (NHCOCH3); 
HR MS: m/z: calcd for C49H60N2O24: 530.1773; found: 530.1775 [M]2-.  
Compound 36 (6mg, 5.4 μmol) and the sulfur trioxide–trimethylamine 
complex (26 mg, 0.19 mmol) were dissolved in dry DMF (1.5 mL) and 
heated at 100 °C for 2 h using microwave radiation (20 W average power). 
The reaction vessel was cooled and Et3N (150 μL) and MeOH (1 mL) were 
added. The solution was layered on the top of a Sephadex LH-20 
chromatography column which was eluted with MeOH to obtain 37 as 
triethylammonium salt. The residue was converted into the sodium salt by 
elution from a column of Dowex 50WX4-Na+ with MeOH–H2O 9 : 1 (5 mg, 
56%). 1H-NMR (500 MHz, D2O, 40 ºC, data for sodium salt):  7.62 (m, 
2H, Ar), 7.50-7.36 (m, 8H, Ar), 7.12 (m, 2H, Ar), 7.00 (m, 2H, Ar), 5.31 (d, 
1H, J1,2 = 8.5 Hz, H-1A), 4.96 (m, 2H, H-4A and H-4C), 4.93-4.85 (m, 4H, 
H-1B or D, H-4D and CH2(Bn)), 4.80-4.71 (m, 4H, H-1C, H-1D or B, and 
CH2(Bn)), 4.41 (m, 2H, H-2B and H-2D), 4.36-4.23 (m, 5H, H-3D or H-5D, 
H-3A and 3 x H-6A or C), 4.20 (m, 2H, H-3D or H-5D, and H-5A or C), 
4.15 (m, 2H, H-4B and H-3C), 4.10 (m, 1H, H-6A or C), 3.99 (m, 2H, H-
2C and H-2A), 3.93 (m, 1H, H-5A or C), 3.88 (pt, 1H, H-3B), 3.83 (s, 3H, 
OCH3), 3.81 (m, 1H, H-5B), 2.09 (NHCOCH3), 2.08 (NHCOCH3); 
13C-NMR (125 MHz, D2O, 40ºC) (selected data from HSQC experiment):  
130.6-116.4 (Ar), 103.8 (C-1D or B), 102.4 (C-1B or D), 101.6 (C-1A), 
101.4 (C-1C), 81.6 (C-3B), 80.0 (C-2B and 2D), 80.0 (C-5A/C or C-3D or 
C-5D) 79.5 (C-3D or 5D), 78.7 (C-5B), 78.6 (C-3C and C-4B), 77.9 (C-3A), 
77.2 (C-4D), 76.9 (C-4A and C-4C), 75.1 (CH2(Bn)), 74.2 (CH2(Bn)), 74.1 
(C-5A/C or C-3D or C-5D), 73.4 (C-5A or 5C), 69.3 (C-6A or 6C), 68.6 
(C-6A or 6C), 57.2 (OCH3), 53.9 (C-2A and C-2C), 23.9 (2x NHCOCH3). 
4-Methoxyphenyl O-(2,4-di-O-sulfo-β-D-glucopyranosyluronic acid)-
(1→3)-O-(2-acetamido-2-deoxy-4,6-di-O-sulfo-β-D-galactopyranosyl)-
(1→4)-O-(2-O-sulfo-β-D-glucopyranosyluronic acid)-(1→3)-2-
acetamido-2-deoxy-4,6-di-O-sulfo-β-D-galactopyranoside (38): A 
solution of 37 (4.0 mg, 2.5 µmol, sodium salt) in H2O/MeOH (3.6 mL/0.4 
mL) was hydrogenated at 1.5 bar pressure  in the presence of Pd(OH)2 (12 
mg). After 24h, the suspension was filtered over celite and concentrated to 
give 38 after lyophilisation (3.4 mg, 97 %). 1H-NMR (500 MHz, D2O, data 
for sodium salt):  7.10 (m, 2H, Ar), 6.99 (m, 2H, Ar), 5.22 (d, 1H, J1,2 = 
8.5 Hz, H-1A), 4.95 (d, 1H, J3,4 = 2.6 Hz, H-4A), 4.93 (d, 1H, J3,4 = 2.4 Hz, 
H-4C), 4.77 (m, 2H, H-1C and H-1D), 4.71 (d, 1H, J1,2 = 7.9 Hz, H-1B), 
4.51 (pt, 1H, H-4D), 4.36-4.31 (m, 2H, 2 x H-6A or C), 4.28-4.21 (m, 6H, 2 
x H-6A or C, H-5A or C, H-2D, H-3A and H-2B), 4.16-4.08 (m, 3H, H-3C, 
H-5A or C, and H-2A), 4.03 (pt, 1H, H-3D), 3.98 (d, 1H, J4,5 = 8.5 Hz, H-
5D), 3.93 (m, 2H, H-4B and H-2C), 3.85-3.81 (m, 4H, H-3B and OCH3), 
3.72 (d, 1H, J4,5 = 9.6 Hz, H-5B), 2.07 (NHCOCH3), 2.06 (NHCOCH3); 
13C-NMR (125 MHz, D2O) (selected data from HSQC experiment):  119.6 
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(Ar), 116.2 (Ar), 103.8 (C-1B), 102.9 (C-1D), 102.6 (C-1C), 101.7 (C-1A), 
81.5 (C-4B), 80.7 (C-2B and C-2D), 79.0 (C-4D), 77.9 (C-3A), 77.8 (C-5B), 
77.5 (C-3C and C-5D), 77.0 (C-4A and C-4C), 74.4 (C-3B), 74.2 (C-3D), 
73.9 (C-5A or C), 73.5 (C-5A or C), 69.0 (C-6A or C), 68.7 (C-6A or C), 
56.8 (OCH3), 53.3 (C-2A), 23.7 (2xNHCOCH3). ESI MS: m/z: calcd for 
C35H41N2O45S7Na7: 796.9; found: 796.7 [M+7Na]2-.  
4-Methoxyphenyl 3-O-(methyl 3-O-benzyl-2,4-di-O-pivaloyl-α-L-
idopyranosyluronate)-2-deoxy-4,6-O-di-tert-butylsilylene-2-
trifluoroacetamido-β-D-galactopyranoside (40): Compound 39 (427 mg, 
0.428 mmol) was dissolved in CH2Cl2 (8.5 mL) and hydrazine monohydrate 
(3.42 mL of a 0.5 M solution in Py/AcOH 3:2) was added. After stirring at 
room temperature for 3h, the reaction mixture was quenched with acetone 
(5.0 mL). The mixture was diluted with CH2Cl2 and washed with 1 M HCl 
aqueous solution, saturated NaHCO3 aqueous solution and H2O. The 
organic layer was dried (MgSO4), filtered and concentrated in vacuo to give 
the corresponding diol that was used for the next step without further 
purification [TLC (toluene-EtOAc 1:2) Rf 0.20]. This diol was dissolved in 
Py (9 mL). Pivaloyl chloride (2.5 mL) and DMAP (21 mg, 0.17 mmol) 
were added and the solution was stirred at room temperature. After 45 h, 
the mixture was diluted with CH2Cl2, washed with 1 M HCl aqueous 
solution, saturated NaHCO3 aqueous solution and H2O, dried (MgSO4), 
filtered, and concentrated in vacuo. The residue was purified by flash 
column chromatography (toluene-EtOAc 6:1) to yield 40 (363 mg, 87%; 2 
steps). TLC (toluene-EtOAc 4:1) Rf 0.40; [α]20D –19º (c 1.0, CHCl3);  
1H-NMR (400 MHz, CDCl3): δ 7.39-7.26 (m, 5H, Ar), 6.94 (m, 2H, Ar), 
6.79 (m, 2H, Ar), 6.66 (d, 1H, J2,NH = 7.2 Hz, NH), 5.31 (d, 1H, J1,2 = 8.4 
Hz, H-1A), 5.29 (m, 1H, H-4B), 5.15 (d, 1H, J4,5 = 2.0 Hz, H-5B), 5.04 (bs, 
1H, H-1B), 4.86 (m, 1H, H-2B), 4.79 (2d, 2H, CH2(Bn)), 4.53 (d, 1H, J3,4 = 
2.8 Hz, H-4A), 4.39 (dd, 1H, J2,3 = 11.0 Hz, H-3A), 4.20 (m, 2H, H-6aA, 
H-6bA), 3.98 (dt, 1H, H-2A), 3.76 (s, 3H,  Me(OMP) or COOMe), 3.74 (m, 
4H, H-3B, Me(OMP) or COOMe), 3.47 (bs, 1H, H-5A), 1.19, 1.17, 1.08, 
0.97 (4s, 36H, C(CH3)3); 13C-NMR (100 MHz, CDCl3): δ 177.9, 177.6 
(CO(Piv)), 169.1 (COOMe), 157.9 (q, JC,F = 37.2 Hz, COCF3), 156.0, 151.2, 
137.9 (Ar C), 128.5, 127.7, 127.5, 120.0 (Ar-CH), 115.6 (q, JC,F = 288.4 Hz, 
COCF3), 114.6 (Ar-CH), 101.4 (C-1B), 99.2 (C-1A), 78.8 (C-3A), 74.0 
(C-3B), 72.7 (C-4A), 72.5 (CH2(Bn)), 71.3 (C-5A), 67.7 (C-4B), 67.5 (C-
2B), 67.0 (C-6A), 66.9 (C-5B), 55.7 (COOMe or Me(OMP)), 54.1 (C-2A), 
52.4 (COOMe or Me(OMP)), 39.1, 38.8 (C(CH3)3, Piv), 27.8, 27.4, 27.3, 
27.1 (C(CH3)3), 23.3, 21.0 (C(CH3)3); HR MS: m/z: calcd for 
C47H66F3NO15SiNa: 992.4052; found: 992.4087 [M+Na]+.  
4-Methoxyphenyl 3-O-(methyl 3-O-benzyl-2,4-di-O-pivaloyl-α-L-
idopyranosyluronate)-2-deoxy-4,6-di-O-levulinoyl-2-
trifluoroacetamido-β-D-galactopyranoside (41): An excess of (HF)n·Py 
(1.85 mL, 71.1 mmol) was added at 0°C under an argon atmosphere to a 
solution of 40 (363 mg, 0.374 mmol) in dry THF (8.0 mL). After 24 h at 
0ºC the mixture was diluted with CH2Cl2 and washed with H2O and 
saturated NaHCO3 solution until neutral pH. The organic layers were dried 
(MgSO4), filtered and concentrated in vacuo to give the corresponding diol 
(290 mg) that was used for the next step without further purification [TLC 
(toluene-EtOAc 1:6) Rf 0.45]. LevOH (0.72 mL, 7.0 mmol) was added at 
0ºC to a solution of 1,3-dicyclohexylcarbodiimide (721 mg, 3.5 mmol) in 
CH2Cl2 (6 mL). After stirring for 5 min at room temperature, the mixture 
was cooled, filtered and concentrated to give quantitatively levulinic 
anhydride (Lev2O, 3.5 mmol). A solution of the diol (290 mg) in dry Py (10 
mL) was added under an argon atmosphere to a flask containing Lev2O (3.5 
mmol) and DMAP (44 mg, 0.35 mmol). After stirring for 26 h at room 
temperature, the reaction mixture was diluted with CH2Cl2 and washed with 
1M HCl aqueous solution, saturated NaHCO3 aqueous solution and brine. 
The organic layers were dried (MgSO4), filtered and concentrated in vacuo. 
In order to complete the reaction, this residue was dissolved again in dry Py 
(10 mL) and was added under an argon atmosphere to a flask containing 
additional Lev2O (3.5 mmol) and DMAP (44 mg, 0.35 mmol). After stirring 
for 26 h at room temperature, the reaction mixture was diluted with CH2Cl2 
and washed with 1M HCl aqueous solution, saturated NaHCO3 aqueous 
solution and brine. The organic layers were dried (MgSO4), filtered and 
concentrated in vacuo. The residue was purified by column 
chromatography (toluene-EtOAc 2:1) to afford 41 (311 mg, 81%). TLC 
(toluene-EtOAc 1:1) Rf 0.30; 1H-NMR (300 MHz, CDCl3): δ 7.36-7.26 (m, 
5H, Ar), 6.95 (m, 2H, Ar), 6.79 (m, 3H, NH, Ar), 5.41 (d, 1H, J3,4 = 3.2 Hz, 
H-4A), 5.26 (m, 2H, H-4B, H-1A), 4.98 (bs, 1H, H-1B), 4.86 (d, 1H, J4,5 = 
2.4 Hz, H-5B), 4.83 (bt, 1H, H-2B), 4.71 (m, 2H, CH2(Bn)), 4.50 (dd, 1H, 
J2,3 = 10.9 Hz, J3,4 = 3.3 Hz, H-3A), 4.16 (dd, 1H, J5,6a = 7.4 Hz, J6a,6b = 11.4 
Hz, H-6aA), 4.09 (dd, 1H, J5,6a = 5.8 Hz, H-6bA), 3.98 (m, 1H, H-2A), 3.93 
(bt, 1H, H-5A), 3.76 (s, 6H, Me(OMP), COOMe), 3.69 (bt, 1H, H-3B), 
2.72-2.23 (m, 8H, CH2(Lev)), 2.16, 2.08 (2s, 6H, CH3(Lev)), 1.18, 1.14 (2s, 
18H, CH3(Piv)); 13C-NMR (75 MHz, CDCl3): δ 206.8, 206.3 (CO(Lev)), 
177.8, 177.5, 172.2, 172.1 (CO(Lev, Piv)), 168.9 (COOMe), 158.0 (q, JC,F = 
37.3 Hz, COCF3), 155.9, 151.1, 137.6 (Ar-C), 128.0, 127.9, 119.0 (Ar-CH), 
115.7 (q, JC,F = 288.2 Hz, COCF3), 114.7 (Ar-CH), 100.9 (C-1B), 99.2 (C-
1A), 75.4 (C-3A), 74.4 (C-3B), 72.6 (CH2(Bn)), 71.4 (C-5A), 68.6 (C-4A), 
68.0 (C-2B), 67.8 (C-4B), 67.1 (C-5B), 61.9 (C-6A), 55.7 (COOMe or 
Me(OMP)), 54.7 (C-2A), 52.4 (COOMe or Me(OMP)), 39.0, 38.7 (C(CH3)3 
(Piv)), 38.0, 37.9 (CH2(Lev)), 29.9, 29.7 (CH3(Lev)), 27.9, 27.8 (CH2(Lev)), 
27.2, 27.0 (C(CH3)3 (Piv)); HR MS: m/z: calcd for C49H62F3NO19Na: 
1048.3766; found: 1048.3790 [M+Na]+.  
3-O-(Methyl 3-O-benzyl-2,4-di-O-pivaloyl-α-L-idopyranosyluronate)-2-
deoxy-4,6-di-O-levulinoyl-2-trifluoroacetamido-α,β-D-galactopyranose 
(42): CAN (1.6 mL of a 0.63 M solution in H2O) was added to a solution of 
41 (346 mg, 0.337 mmol) in CH2Cl2/MeCN (1:2; 15 mL). After stirring for 
1 h 30 min at room temperature, the reaction mixture was diluted with 
EtOAc, washed with H2O, saturated aqueous NaHCO3, and H2O. The 
organic phase was dried (MgSO4), filtered and concentrated to dryness. The 
residue was purified by column chromatography (toluene-acetone 7:2) to 
afford 42 (218 mg, 70%) as a mixture of α/β anomers. TLC (toluene-
acetone 7:2) Rf 0.20 and 0.11; 1H-NMR (300 MHz, CDCl3) (data for α 
anomer): δ 7.40-7.26 (m, 5H, Ar), 6.65 (d, 1H, J2,NH = 9.5 Hz, NH), 5.35 (m, 
2H, H-4A, H-1A), 5.20 (bt, 1H, H-4B), 5.02 (bs, 1H, H-1B), 4.80 (d, 1H, 
J4,5 = 2.4 Hz, H-5B),  4.76 (m, 1H, H-2B), 4.74-4.62 (2d, 2H, CH2(Bn)), 
4.53 (dt, 1H, J1,2 = 3.5 Hz, J2,3 = 10.6 Hz, H-2A), 4.34 (dd, 1H, J5,6a = 3.7 
Hz, J5,6b = 8.8 Hz, H-5A), 4.22 (dd, 1H, J6a,6b = 11.5 Hz, H-6aA), 4.10 (dd, 
1H, J3,4 = 3.1 Hz, H-3A), 3.95 (dd, 1H, H-6bA), 3.77 (s, 3H, COOMe), 3.70 
(bt, 1H, H-3B), 2.82-2.26 (m, 8H, CH2(Lev)), 2.19, 2.05 (2s, 6H, 
CH3(Lev)), 1.18, 1.15 (2s, 18H, (CH3)3 (Piv)); 13C-NMR (75 MHz, CDCl3) 
(data for α anomer): δ 208.5, 206.7 (CO(Lev)), 177.8, 177.6, 172.3 
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(CO(Lev, Piv)), 169.0 (COOMe), 157.7 (q, JC,F = 37.2 Hz, COCF3), 137.5 
(Ar-C), 128.5, 128.1, 128.0 (Ar-CH), 115.9 (q, JC,F = 288.0 Hz, COCF3), 
101.1 (C-1B), 91.7 (C-1A), 75.5 (C-3A), 73.7 (C-3B), 72.4 (CH2(Bn)), 69.4 
(C-4A), 67.9 (C-4B), 67.5 (C-2B), 67.0 (C-5B), 66.9 (C-5A), 62.7 (C-6A), 
52.4 (COOMe), 50.2 (C-2A), 39.0, 38.7 (C(CH3)3 (Piv)), 38.3, 37.9 
(CH2(Lev)), 29.9, 29.7 (CH3(Lev)), 28.1, 27.7 (CH2(Lev)), 27.2, 27.1 
(C(CH3)3 (Piv)); HR MS: m/z: calcd for C42H56F3NO18Na: 942.3347; found: 
942.3311 [M+Na]+.  
O-[3-O-(Methyl 3-O-benzyl-2,4-di-O-pivaloyl-α-L-
idopyranosyluronate)-2-deoxy-4,6-di-O-levulinoyl-2-
trifluoroacetamido-α,β-D-galactopyranosyl] trichloroacetimidate (43): 
Trichloroacetonitrile (162 µL, 1.6 mmol) and catalytic DBU (80 µL of a 
0.084 M solution in dry CH2Cl2) were added to a solution of 42 (60 mg, 65 
µmol) in dry CH2Cl2 (1.3 mL). After stirring for 10 h at room temperature, 
the reaction mixture was concentrated to dryness. The residue was purified 
by flash chromatography (toluene-acetone 5:1 + 1% Et3N) to afford 43 (54 
mg, 78%) as a mixture of α/β anomers. TLC (toluene-acetone 3:1) Rf 0.45 
(for α anomer); 1H-NMR (400 MHz, CDCl3) (data for α anomer): δ 8.81 (s, 
1H, NH(TCA)), 7.35-7.26 (m, 5H, Ar), 6.78 (d, 1H, J2,NH = 8.5 Hz, 
NH(TFA)), 6.47 (d, 1H, J1,2 = 3.5 Hz, H-1A), 5.52 (bd, 1H, H-4A), 5.24 (bt, 
1H, H-4B), 5.11 (bs, 1H, H-1B), 4.85 (d, 1H, J4,5 = 2.6 Hz, H-5B), 4.75-
4.67 (m, 4H, H-2B, H-2A, CH2(Bn)), 4.29 (t, 1H, J5,6a = J5,6b = 6.5 Hz, H-
5A), 4.23 (dd, 1H, J2,3 = 11.0 Hz, J3,4 = 3.1 Hz, H-3A), 4.08 (m, 2H, H-6aA, 
H-6bA), 3.77 (s, 3H, COOMe), 3.72 (bt, 1H, H-3B), 2.71-2.17 (m, 8H, 
CH2(Lev)), 2.16, 2.08 (2s, 6H, CH3(Lev)), 1.18, 1.14 (2s, 18H, 
(CH3)3(Piv)); 13C-NMR (100 MHz, CDCl3) (data for α anomer): δ 206.5, 
206.1 (CO(Lev)), 178.0, 177.7, 172.2, 172.0 (CO(Lev, Piv)), 168.9 
(COOMe), 160.3 (C=NH), 157.9 (q, JC,F = 37.9 Hz, COCF3), 137.3 (Ar-C), 
128.6, 128.1, 128.0 (Ar-CH), 115.7 (q, JC,F = 289.0 Hz, COCF3), 101.3 
(C-1B), 94.8 (C-1A), 90.7 (CCl3), 75.2 (C-3A), 73.9 (C-3B), 72.7 
(CH2(Bn)), 70.0 (C-5A), 68.9 (C-2B), 68.4 (C-4A), 67.6 (C-4B), 67.5 
(C-5B), 61.8 (C-6A), 52.5 (COOMe), 49.9 (C-2A), 39.1, 38.8 (C(CH3)3 
(Piv)), 37.9 (CH2(Lev)), 29.9, 29.7 (CH3(Lev)), 27.9, 27.8 (CH2(Lev)), 27.2, 
27.1 (C(CH3)3 (Piv)); ESI MS: m/z: calcd for C44H56Cl3F3N2O18Na: 1085.2; 
found: 1085.5 [M+Na]+.  
4-Methoxyphenyl O-(methyl 3-O-benzyl-2,4-di-O-pivaloyl-α-L-
idopyranosyluronate)-(1→3)-O-(2-deoxy-4,6-di-O-levulinoyl-2-
trifluoroacetamido-β-D-galactopyranosyl)-(1→4)-O-(benzyl 2-O-
benzoyl-3-O-benzyl-β-D-glucopyranosyluronate)-(1→3)-2-deoxy-4,6-O-
di-tert-butylsilylene-2-trifluoroacetamido-β-D-galactopyranoside (44): 
Donor 43 (168 mg, 0.158 mmol) and acceptor 32 (103 mg, 0.105 mmol) 
were dissolved in dry CH2Cl2 (3.0 mL) in the presence of freshly activated 
4Å molecular sieves. After stirring for 30 min at 0ºC, TMSOTf (343 µL of 
a 0.092 M solution in dry CH2Cl2) was added under an argon atmosphere. 
After stirring for 30 min at 0ºC, the reaction mixture was neutralized with 
Et3N, filtered and concentrated to dryness. The residue was purified by 
column chromatography (toluene-acetone 7:1) to afford 44 (106 mg, 53%). 
TLC (toluene-acetone 3:1) Rf 0.55; [α]20D –2º (c 1.0, CHCl3); 1H-NMR 
(400 MHz, CDCl3): δ 7.92 (d, 2H, Ar), 7.56 (t, 1H, Ar), 7.49-7.22 (m, 12H, 
Ar), 7.07 (m, 5H, Ar), 6.95 (d, 1H, J2,NH = 6.5 Hz, NH), 6.90 (m, 2H, Ar), 
6.78 (m, 2H, Ar), 6.68 (d, 1H, J2,NH = 8.9 Hz, NH), 5.37 (d, 1H, J1,2 = 8.2 
Hz, H-1A), 5.30 (d, 1H, J1,2 = 7.9 Hz, H-1B), 5.28 (m, 2H, CH2(Bn)), 5.24 
(m, 1H, H-4D), 5.21 (t, 1H, H-2B), 5.17 (d, 1H, J3,4 = 3.1 Hz, H-4C), 4.95 
(bs, 1H, H-1D), 4.91 (d, 1H, J4,5 = 2.2 Hz, H-5D), 4.84 (d, 1H, CH2(Bn)), 
4.77 (bs, 1H, H-2D), 4.72-4.66 (2d, 2H, CH2(Bn)), 4.57 (bs, 1H, H-4A), 
4.51 (d, 1H, CH2(Bn)), 4.36 (bd, 1H, J2,3 = 11.3 Hz, H-3A), 4.24 (d, 1H, J1,2 
= 8.5 Hz, H-1C), 4.17-3.98 (m, 4H, H-2C, H-6aA, H-4B, H-6bA), 3.97-
3.93 (m, 2H, H-2A, H-5B), 3.87 (m, 2H, H-6aC, H-6bC), 3.78, 3.75 (2s, 6H, 
Me(OMP), COOMe), 3.68 (m, 2H, H-3B, H-3D), 3.57 (dd, 1H, J2,3 = 10.5 
Hz, H-3C), 3.45 (t, 1H, J5,6a = J5,6b = 6.5 Hz, H-5C), 3.32 (m, 1H, H-5A), 
2.68 (m, 2H, CH2(Lev)), 2.48-2.16 (m, 8H, CH2(Lev), CH3(Lev) (2.17)), 
2.10-2.04 (m, 1H, CH2(Lev)), 1.96 (s, 3H, CH3(Lev)), 1.20, 1.18, 1.05, 1.01 
(4s, 36H, C(CH3)3); 13C-NMR (100 MHz, CDCl3): δ 206.9, 206.1 
(CO(Lev)), 177.9, 177.3, 172.2, 172.0, 169.1, 168.9, 165.1 (CO(Lev), 
CO(Piv), CO(Bz), COOBn, COOMe), 158.2 (q, JC,F = 37.1 Hz, COCF3), 
157.7 (q, JC,F = 36.8 Hz, COCF3), 156.0, 151.1, 137.8, 137.6, 134.6 (Ar-C), 
133.4, 129.9, 129.7, 129.5, 129.4, 129.3, 128.5, 128.2, 128.0, 127.7, 120.3 
(Ar-C, Ar-CH), 116.0 (q, JC,F = 288.3 Hz, COCF3), 115.5 (q, JC,F = 288.6 Hz, 
COCF3), 114.6 (Ar-CH), 100.4 (C-1D), 100.2, 100.1 (C-1B, C-1C), 99.3 
(C-1A), 80.2 (C-3B), 78.3 (C-4B), 76.5 (C-3C), 75.3 (CH2(Bn)), 75.2 (C-
3A), 74.2 (C-3D), 74.1 (C-5B), 73.4 (C-4A), 72.5 (CH2(Bn)), 72.4 (C-2B), 
71.4 (C-5A), 71.2 (C-5C), 68.5 (CH2(Bn)), 68.1 (C-4C), 67.8 (C-4D, C-2D), 
67.6 (C-6A), 67.0 (C-5D), 61.4 (C-6C), 55.7 (COOMe or Me(OMP)), 54.1 
(C-2A), 53.3 (C-2C), 52.4 (COOMe or Me(OMP)), 39.1, 38.7 (C(CH3)3 
(Piv)), 38.0, 37.8 (CH2(Lev)), 29.9, 29.6 (CH3(Lev)), 28.0, 27.7 (CH2(Lev)), 
27.6, 27.3, 27.1 (C(CH3)3), 23.4, 20.8 (C(CH3)3 (DBSi)); HRMS: m/z: calcd 
for C92H112F6N2O31SiNa: 1905.6820; found: 1905.6755 [M+Na]+.  
4-Methoxyphenyl O-(methyl 3-O-benzyl-2,4-di-O-pivaloyl-α-L-
idopyranosyluronate)-(1→3)-O-(2-deoxy-2-trifluoroacetamido-β-D-
galactopyranosyl)-(1→4)-O-(benzyl 2-O-benzoyl-3-O-benzyl-β-D-
glucopyranosyluronate)-(1→3)-2-deoxy-4,6-O-di-tert-butylsilylene-2-
trifluoroacetamido-β-D-galactopyranoside (45): Compound 44 (105 mg, 
0.056 mmol) was dissolved in CH2Cl2 (1.5 mL) and hydrazine monohydrate 
(0.45 mL of a 0.5 M solution in Py/AcOH 3:2) was added. After stirring at 
room temperature for 3h, the reaction mixture was quenched with acetone 
(0.7 mL). The mixture was diluted with CH2Cl2 and washed with 1 M HCl 
aqueous solution, saturated NaHCO3 aqueous solution and H2O. The 
organic layer was dried (MgSO4), filtered and concentrated in vacuo. The 
residue was purified by flash column chromatography (toluene-EtOAc 6:1) 
to yield 45 (82 mg, 87%). TLC (toluene-EtOAc 3:2) Rf 0.32; [α]20D –7º (c 
1.0, CHCl3); 1H-NMR (400 MHz, CDCl3): δ 7.97 (d, 2H, Ar), 7.57 (t, 1H, 
Ar), 7.46-7.33 (m, 12H, Ar), 7.13 (m, 5H, Ar), 6.91 (m, 2H, Ar), 6.80 (m, 
3H, Ar, NH), 6.52 (d, 1H, J2,NH = 8.4 Hz, NH), 5.38 (d, 1H, J1,2 = 8.3 Hz, 
H-1A), 5.30-5.20 (m, 5H, H-1B, H-2B, CH2(Bn), H-4D), 5.08 (bd, 1H, H-
1D), 4.94 (d, 1H, J4,5 = 2.7 Hz, H-5D), 4.86 (d, 1H, CH2(Bn)), 4.85 (bd, 1H, 
H-2D), 4.79-4.68 (2d, 2H, CH2(Bn)), 4.58 (bs, 1H, H-4A), 4.54 (d, 1H, 
CH2(Bn)), 4.38 (bd, 1H, J2,3 = 11.1 Hz, H-3A), 4.27 (d, 1H, J1,2 = 8.5 Hz, 
H-1C), 4.24 (m, 1H, H-2C), 4.11 (d, 1H, J6a,6b = 12.3 Hz, H-6aA), 4.05 (t, 
1H, J3,4 = J4,5 = 9.5 Hz, H-4B), 3.99 (m, 1H, H-6bA), 3.98-3.91 (m, 3H, H-
5B, H-2A, H-4C), 3.76-3.75 (2s, 6H, COOMe, Me(OMP)), 3.70 (m, 2H, H-
3D, H-3B), 3.56-3.45 (m, 3H, H-6aC, H-6bC, H-3C), 3.32 (m, 1H, H-5A), 
3.12 (m, 1H, H-5C), 1.20, 1.18, 1.06, 1.02 (4s, 36H, C(CH3)3); 13C-NMR 
(100 MHz, CDCl3): δ 177.6, 177.4, 169.0, 168.7, 165.1 (CO(Piv), CO(Bz), 
COOBn, COOMe), 157.9 (q, JC,F = 36.9 Hz, COCF3), 157.7 (q, JC,F = 36.7 
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Hz, COCF3), 156.0, 151.1, 137.7, 137.2, 134.7 (Ar-C), 133.5, 129.9, 129.5, 
129.4, 129.2, 129.1, 128.6, 128.5, 128.3, 128.1, 128.0, 127.8, 120.3 (Ar-C, 
Ar-CH), 116.0 (q, JC,F = 288.3 Hz, COCF3), 115.5 (q, JC,F = 288.3 Hz, 
COCF3), 114.6 (Ar-CH), 100.4 (C-1B), 100.2 (C-1C), 99.6 (C-1D), 99.3 
(C-1A), 80.6 (C-3B), 79.0 (C-3C), 78.0 (C-4B),  75.8 (CH2(Bn)), 75.5 (C-
3A), 74.6 (C-5C), 74.1 (C-5B), 73.7 (C-3D), 73.3 (C-4A), 72.6 (C-2B), 
72.4 (CH2(Bn)), 71.4 (C-5A), 68.3 (CH2(Bn), C-4C), 68.2 (C-2D), 67.8 (C-
5D), 67.0 (C-4D, C-6A), 62.3 (C-6C), 55.7 (COOMe or Me(OMP)), 54.1 
(C-2A), 52.5 (COOMe or Me(OMP)), 52.3(C-2C), 39.1, 38.8 (C(CH3)3 
(Piv)), 27.6, 27.3, 27.1 (C(CH3)3), 23.4, 20.8 (C(CH3)3 (DBSi)); HRMS: 
m/z: calcd for C82H100F6N2O27SiNa: 1709.6085; found: 1709.6031 [M+Na]+. 
4-Methoxyphenyl O-(methyl 3-O-benzyl-2,4-di-O-pivaloyl-α-L-
idopyranosyluronate)-(1→3)-O-(2-deoxy-2-trifluoroacetamido-β-D-
galactopyranosyl)-(1→4)-O-(benzyl 2-O-benzoyl-3-O-benzyl-β-D-
glucopyranosyluronate)-(1→3)-2-deoxy-2-trifluoroacetamido-β-D-
galactopyranoside (46): An excess of (HF)n·Py (223 µL, 8.6 mmol) was 
added at 0°C under an argon atmosphere to a solution of 45 (75 mg, 0.044 
mmol) in dry THF (4.0 mL). After 24 h at 0ºC the mixture was diluted with 
CH2Cl2 and washed with H2O and saturated NaHCO3 solution until neutral 
pH. The organic layers were dried (MgSO4), filtered and concentrated in 
vacuo to give 46 (67 mg, 97%). TLC (toluene-EtOAc 1:2) Rf 0.20; [α]20D –
3º (c 1.0, CHCl3); 1H-NMR (400 MHz, CDCl3): δ 7.85 (d, 2H, Ar), 7.56 (t, 
1H, Ar), 7.44-7.26 (m, 13H, Ar, NH), 7.10-7.03 (m, 5H, Ar), 6.83 (m, 2H, 
Ar), 6.72 (m, 2H, Ar), 6.64 (m, 1H, NH), 5.37 (m, 1H, H-1A), 5.29 (m, 1H, 
H-2B), 5.22 (m, 3H, H-4D, CH2(Bn)), 5.06 (bd, 1H, H-1D), 4.93 (d, 1H, 
J4,5 = 2.8 Hz, H-5D), 4.87 (d, 1H, CH2(Bn)), 4.84 (m, 1H, H-2D), 4.81 (d, 
1H, J1,2 = 7.4 Hz, H-1B), 4.77-4.56 (3d, 3H, CH2(Bn)), 4.48 (m, 2H, H-1C, 
H-3A), 4.31 (t, 1H, J3,4 = J4,5 = 8.8 Hz, H-4B), 4.16 (m, 1H, H-2C), 4.14 (bs, 
1H, H-4A), 4.06 (bd, 1H, H-5B), 3.93 (bd, 1H, J3,4 = 2.6 Hz, H-4C), 3.88 
(m, 1H, H-2A), 3.83-3.70 (m, 9H, H-6aA, H-3B, H-3D, Me(OMP), 
COOMe), 3.59 (m, 4H, H-6bA, H-6aC, H-3C, H-5A), 3.48 (dd, 1H, J5,6b = 
2.8 Hz, J6a,6b = 12.1 Hz, H-6bC), 3.26 (m, 1H, H-5C), 2.29 (m, 4H, OH), 
1.19, 1.18 (2s, 18H, C(CH3)3); 13C-NMR (100 MHz, CDCl3) (selected data 
from HSQC experiment): δ 133.7, 130.2, 129.7-127.6, 119.1, 114.7 (Ar-
CH), 101.7 (C-1B), 100.1 (C-1C), 99.6 (C-1D), 98.7 (C-1A), 80.5 (C-3B), 
78.8 (C-3C), 78.6 (C-3A), 77.4 (C-4B), 75.9 (CH2(Bn)), 75.2 (C-5C), 74.5 
(C-5A), 74.2 (C-5B), 74.1 (C-3D), 72.8 (C-2B), 72.7 (CH2(Bn)), 68.8 
(CH2(Bn)), 68.6 (C-4A, C-4C, C-2D), 68.0 (C-5D), 67.6 (C-4D), 62.7 
(C-6C), 62.5 (C-6A), 55.9 (COOMe or Me(OMP)), 54.5 (C-2A), 52.8 
(C-2C, COOMe or Me(OMP)), 27.5 (C(CH3)3); HRMS: m/z: calcd for 
C74H84F6N2O27Na: 1569.5063; found: 1569.5101 [M+Na]+.  
4-Methoxyphenyl O-(methyl 3-O-benzyl-2,4-di-O-pivaloyl-α-L-
idopyranosyluronate)-(1→3)-O-(2-deoxy-4,6-di-O-sulfo-2-
trifluoroacetamido-β-D-galactopyranosyl)-(1→4)-O-(benzyl 2-O-
benzoyl-3-O-benzyl-β-D-glucopyranosyluronate)-(1→3)-2-deoxy-4,6-di-
O-sulfo-2-trifluoroacetamido-β-D-galactopyranoside (47): Compound 46 
(16 mg, 10 µmol) and sulfur trioxide–trimethylamine complex (58 mg, 0.41 
mmol) were dissolved in dry DMF (1.5 mL) and heated at 100ºC for 30 min 
using microwave radiation (23 W average power). The reaction vessel was 
cooled and Et3N (300 µL), MeOH (1 mL) and CH2Cl2 (1 mL) were added. 
The solution was layered on the top of a Sephadex LH 20 chromatography 
column which was eluted with CH2Cl2-MeOH (1:1) to obtain 47 as 
triethylammonium salt (23 mg, quantitative). TLC (EtOAc:Py:H2O:AcOH 
12:5:3:1) Rf 0.14; 1H-NMR (500 MHz, CD3OD/CDCl3 7:1): δ 7.94 (d, 2H, 
Ar), 7.62 (t, 1H, Ar), 7.54-7.05 (m, 17H, Ar), 6.97 (d, 2H, Ar), 6.82 (d, 2H, 
Ar), 5.68 (d, 1H, J4,5 = 2.7 Hz, H-5D), 5.43 (d, 1H, J = 11.8 Hz, CH2(Bn)), 
5.34 (dd, 1H, H-4D), 5.26-5.22 (m, 2H, H-2B, CH2(Bn)), 5.05 (d, 1H, J1,2 = 
2.4 Hz, H-1D), 5.02-4.97 (m, 2H, H-2D, CH2(Bn)), 4.90 (d, 1H, J1,2 = 7.8 
Hz, H-1B), 4.85-4.80 (m, 3H, H-1A, H-4A, H-4C), 4.76 (d, 1H, J1,2 = 8.4 
Hz, H-1C), 4.70 (m, 2H, CH2(Bn)), 4.52-4.43 (m, 3H, CH2(Bn), 2 x H-6A 
or C), 4.40-4.35 (m, 2H, H-4B, H-6A or C),  4.33-4.25 (m, 2H, H-6A or C, 
H-2C), 4.20-4.08 (m, 3H, H-2A, H-3A, H-5B), 4.01 (dd, 1H, J2,3 = 11.0 Hz, 
J3,4 = 3.0 Hz, H-3C), 3.97-3.94 (m, 2H, H-5A, H-5C), 3.85 (dd, 1H, H-3B), 
3.78-3.74 (2s, 6H, Me(OMP), COOMe), 3.61 (dd, 1H, H-3D), 3.16 (q, 24H, 
Et3NH+), 1.28 (t, 36H, Et3NH+), 1.18, 1.14 (2s, 18H, C(CH3)3); 13C-NMR 
(125 MHz, CD3OD/CDCl3 7:1) (selected data from HSQC experiment): δ 
128.3-114.1 (Ar-CH), 101.6 (C-1B), 101.1 (C-1D), 100.7 (C-1C), 99.3 (C-
1A), 79.9 (C-3B), 76.9 (C-3A), 75.8 (C-4B), 75.4-75.1 (C-4A, C-4C, C-3C), 
74.9 (C-3D), 74.6-74.5 (C-5B, CH2(Bn)),  73.4 (C-5A, C-5C), 72.6 (C-2B), 
71.4 (CH2(Bn)), 69.2 (C-4D), 68.8 (C-2D), 68.0-67.5 (CH2(Bn), C-6C, C-
6A, C-5D), 54.6 (COOMe or Me(OMP)), 53.0 (C-2A), 51.8 (C-2C), 51.5 
(COOMe or Me(OMP)), 26.3 (C(CH3)3); ESI MS: m/z: calcd for 
C74H81F6N2O39S4Na: 943.2; found: 943.3 [M+Na+H]2.   
4-Methoxyphenyl O-(3-O-benzyl-α-L-idopyranosyluronic acid)-(1→3)-
O-(2-acetamido-2-deoxy-4,6-di-O-sulfo-β-D-galactopyranosyl)-(1→4)-
O-(3-O-benzyl-β-D-glucopyranosyluronic acid)-(1→3)-2-acetamido-2-
deoxy-4,6-di-O-sulfo-β-D-galactopyranoside (49): H2O2 (30%, 0.19 mL) 
and an aqueous solution of LiOH (0.7 M, 0.12 mL) were added at 0ºC to a 
solution of 47 (11 mg, 4.8 µmol) in THF (0.5 mL). After stirring for 24 h at 
room temperature, MeOH (1.0 mL), H2O (0.3 mL) and an aqueous solution 
of NaOH (4 M, 0.24 mL) were added. After stirring for 72 h at room 
temperature, the reaction mixture was neutralized with Amberlite IR-120 
(H+) resin, filtered, and concentrated to give 48 [ESI MS: m/z: calcd for 
C45H54N2O34S4Na2: 670.0; found: 669.9 [M+2Na+2H]2-]. Triethylamine (9 
µL, 64 µmol) and acetic anhydride (9 µL, 97 µmol) were added to a cooled 
(0ºC) solution of 48 in dry MeOH (1.5 mL). After stirring for 2 h at r.t., 
Et3N (200 µL) was added and the mixture was concentrated to dryness. The 
residue was purified by Sephadex LH-20 chromatography (MeOH 100%) 
to give 49. This compound was then dissolved in H2O (2 mL) and 
Amberlite IR-120 H+ resin was added (pH = 3.3). The mixture was filtered, 
treated with 0.04 M NaOH (pH = 7.5) and lyophilized. The white solid was 
finally eluted from a column of Dowex 50WX4-Na+ (H2O-MeOH 9:1) to 
obtain 49 as sodium salt (6 mg, 86%) after lyophilization. TLC 
(EtOAc:Py:H2O:AcOH 6:5:3:1) Rf 0.17; 1H-NMR (500 MHz, D2O): δ 
7.57-7.36 (m, 10H, Ar), 7.09 (d, 2H, Ar), 6.97 (d, 2H, Ar), 5.03 (d, 1H, J1,2 
= 8.5 Hz, H-1A), 4.96 (d, 1H, J = 10.5 Hz, CH2(Bn)), 4.85 (d, 1H, J3,4 = 2.5 
Hz, H-4A), 4.84-4.77 (m, 6H, CH2(Bn), H-5D(4.83), H-1D(4.80), H-
4C(4.76)), 4.70 (d, 1H, J1,2 = 8.0 Hz, H-1C), 4.55 (d, 1H, J1,2 = 7.5 Hz, 
H-1B), 4.35-4.29 (m, 2H, H-2A, H-6A or C), 4.26-4.19 (m, 3H, H-5A or C, 
2 x H-6A or C), 4.16 (dd, 1H, H-3A), 4.14-4.04 (m, 4H, H-6A or C, H-4D, 
H-2C, H-4B), 3.99 (m, 1H, H-5A or C), 3.95 (m, 1H, H-3C), 3.81 (s, 3H, 
Me(OMP)), 3.76 (d, 1H, J4,5 = 9.5 Hz, H-5B), 3.67-3.53 (m, 4H, H-2D, H-
3B, H-2B, H-3D), 2.04, 2.03 (2s, 6H, NHAc); 13C-NMR (125 MHz, D2O) 
(selected data from HSQC experiment): δ 130.1-116.1(Ar-CH), 105.3 
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(C-1D), 104.9 (C-1B), 101.6 (C-1A), 101.3 (C-1C), 82.9 (C-3D), 82.4 (C-
3B), 78.4 (C-4B), 77.8 (C-5B), 77.6 (C-4C, C-3C), 76.9 (C-4A), 75.9 (C-
3A), 74.7, 74.4 (CH2(Bn)), 73.8-73.4 (C-5A, C-5C, C-4D), 72.6 (C-2B), 
71.8 (C-2D), 68.9, 68.5 (C-6A, C-6C), 56.8 (Me(OMP)), 52.9, 52.6 (C-2A, 
C-2C), 23.6 (NAc); ESI MS: m/z: calcd for C49H58N2O36S4Na3: 1447.1; 
found: 1447.0 [M+3Na+2H]-.  
4-Methoxyphenyl O-(α-L-idopyranosyluronic acid)-(1→3)-O-(2-
acetamido-2-deoxy-4,6-di-O-sulfo-β-D-galactopyranosyl)-(1→4)-O-(β-
D-glucopyranosyluronic acid)-(1→3)-2-acetamido-2-deoxy-4,6-di-O-
sulfo-β-D-galactopyranoside (50): A solution of 49 (5.8 mg, 3.8 µmol, 
sodium salt) in H2O/MeOH (4.5 mL/0.5 mL) was hydrogenated in the 
presence of Pd(OH)2 (12 mg). After 24 h, the suspension was filtered over 
celite, concentrated, and lyophilized to give 50 as sodium salt (5.1 mg, 
quantitative). 1H-NMR (500 MHz, D2O): δ 7.09 (d, 2H, Ar), 6.98 (d, 2H, 
Ar), 5.02 (d, 1H, J1,2 = 8.5 Hz, H-1A), 4.85 (d, 1H, J3,4 = 2.6 Hz, H-4A), 
4.83 (d, 1H, J1,2 = 4.5 Hz, H-1D), 4.76 (d, 1H, H-4C), 4.67 (d, 1H, J1,2 = 8.1 
Hz, H-1C), 4.63 (d, 1H, J4,5 = 3.6 Hz, H-5D), 4.53 (d, 1H, J1,2 = 7.8 Hz, 
H-1B), 4.34-4.21 (m, 6H, H-2A (4.31), 2 x H-6A, 2 x H-6C, H-5A or C 
(4.23)), 4.17-4.15 (m, 2H, H-5A or C, H-3A), 4.09-4.02 (m, 2H, H-2C, H-
3C), 3.93 (dd, 1H, H-4D), 3.81 (s, 3H, Me(OMP)), 3.78 (dd, 1H, H-4B), 
3.69 (d, 1H, J4,5 = 9.7 Hz, H-5B), 3.63-3.59 (m, 2H, H-3B, H-3D), 3.49 (dd, 
1H, J2,3 = 7.5 Hz, H-2D), 3.44 (dd, 1H, H-2B), 2.05, 2.03 (2s, 6H, NHAc); 
13C-NMR (125 MHz, D2O) (selected data from HSQC experiment): δ 
119.6-116.2 (Ar), 104.7 (C-1B), 104.1 (C-1D), 102.6 (C-1C), 101.8 (C-1A), 
83.4 (C-4B), 77.8 (C-5B), 77.0 (C-4C, C-4A), 76.5 (C-3C), 76.0 (C-3A), 
75.0 (C-3B or D), 73.7, 73.5 (C-5A, C-5C), 73.4 (C-3B or D), 73.1 (C-2B), 
72.7 (C-4D), 72.3 (C-5D), 71.4 (C-2D), 68.9-68.8 (C-6A, C-6C), 56.9 
(Me(OMP)), 52.7 (C-2A, C-2C), 23.5 (NAc); ESI MS: m/z: calcd for 
C35H46N2O36S4Na3: 1267.0; found: 1266.9 [M+3Na+2H]-.  
Fluorescence polarization assay 
Fluorescence polarization measurements were performed in 384-well 
microplates (black polystyrene, non-treated, Corning) using a TRIAD 
multimode reader (Dynex). Fluorescent probe (a fluorescent heparin-like 
hexasaccharide) and inhibitors were dissolved in PBS buffer (10 mM, pH 
7.4). Recombinant human FGF-2 (Peprotech) was dissolved in PBS buffer 
(10 mM, pH 7.4) containing 1% BSA. For inhibition assay, 10 µL of probe 
solution and 20 µL of protein at fixed concentration (40 nM and 145 nM, 
respectively) were mixed with 10 µL of inhibitor solution (100 µM). The 
total sample volume in each well was 40 µL. Therefore, all measurements 
were done in PBS + 0.5% BSA, and the final concentrations of inhibitor, 
fluorescent probe and FGF-2 in each well were 25 µM, 10 nM and 73 nM, 
respectively.  After stirring for 5 min in the dark, fluorescence polarization 
was recorded. Two control wells were included in the study. The first one 
only contained fluorescent probe; the second one contains FGF-2 and probe, 
without inhibitor.  Blank wells contained 20 µL of FGF-2 solution and 20 
µL of PBS buffer and their measurements were substracted from all values. 
All samples were performed in replicates of three. 
Supporting Information (see footnote on the first page of this article): 
Copies of the NMR spectra of new compounds. 
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